J. Kleeff, M. Korc, M. Apte, L. Vecchia, C. Johnson et al., Pancreatic cancer, Nature reviews Disease primers, vol.2, p.16022, 2016.

E. A. Collisson, A. Sadanandam, P. Olson, W. J. Gibb, M. Truitt et al., Subtypes of pancreatic ductal adenocarcinoma and their differing responses to therapy, Nat Med, vol.17, pp.500-503, 2011.

P. Bailey, D. K. Chang, K. Nones, A. L. Johns, A. M. Patch et al., Genomic analyses identify molecular subtypes of pancreatic cancer, Nature, vol.531, pp.47-52, 2016.

R. A. Moffitt, R. Marayati, E. L. Flate, K. E. Volmar, S. G. Loeza et al., Virtual microdissection identifies distinct tumor-and stroma-specific subtypes of pancreatic ductal adenocarcinoma, Nat Genet, vol.47, pp.1168-78, 2015.

R. Nicolle, Y. Blum, L. Marisa, C. Loncle, O. Gayet et al., Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts, Cell reports, vol.21, pp.2458-70, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01985259

C. Vennin, K. J. Murphy, J. P. Morton, T. R. Cox, M. Pajic et al., Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer, Gastroenterology, vol.154, pp.820-858, 2018.

M. Erkan, C. Reiser-erkan, C. W. Michalski, B. Kong, I. Esposito et al., The impact of the activated stroma on pancreatic ductal adenocarcinoma biology and therapy resistance, Curr Mol Med, vol.12, pp.288-303, 2012.

R. Kalluri, The biology and function of fibroblasts in cancer, Nat Rev Cancer, vol.16, pp.582-98, 2016.

E. S. Knudsen, P. Vail, U. Balaji, H. Ngo, I. W. Botros et al., Stratification of Pancreatic Ductal Adenocarcinoma: Combinatorial Genetic, Stromal, and Immunologic Markers, Clin Cancer Res, vol.23, pp.4429-4469, 2017.

W. Song, R. Mazzieri, T. Yang, and G. C. Gobe, Translational Significance for Tumor Metastasis of Tumor-Associated Macrophages and Epithelial-Mesenchymal Transition, Frontiers in immunology, vol.8, p.1106, 2017.

J. B. Candido, J. P. Morton, P. Bailey, A. D. Campbell, S. A. Karim et al.,

, Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype, Cell reports, vol.23, pp.1448-60, 2018.

S. Mariathasan, S. J. Turley, D. Nickles, A. Castiglioni, K. Yuen et al., TGFbeta attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells, Nature, vol.554, pp.544-552, 2018.

C. Duluc, S. Moatassim-billah, M. Chalabi-dchar, A. Perraud, R. Samain et al., Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancerassociated fibroblasts abrogates pancreatic tumour chemoresistance, EMBO Mol Med, vol.7, pp.735-53, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02421448

S. Moatassim-billah, C. Duluc, R. Samain, C. Jean, A. Perraud et al., Antimetastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancer-associated fibroblasts, Oncotarget, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02421440

Y. Zhu, B. L. Knolhoff, M. A. Meyer, T. M. Nywening, B. L. West et al., CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models, Cancer Res, vol.74, pp.5057-69, 2014.

V. Kumar, L. Donthireddy, D. Marvel, T. Condamine, F. Wang et al.,

, Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors, Cancer Cell, vol.32, pp.654-68, 2017.

S. R. Hingorani, L. Wang, A. S. Multani, C. Combs, T. B. Deramaudt et al., Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice, Cancer Cell, vol.7, pp.469-83, 2005.

A. J. Aguirre, N. Bardeesy, M. Sinha, L. Lopez, D. A. Tuveson et al., Activated Kras and Ink4a/Arf deficiency cooperate to produce metastatic pancreatic ductal adenocarcinoma, Genes Dev, vol.17, pp.3112-3138, 2003.

A. Zhang, Y. Qian, Z. Ye, H. Chen, H. Xie et al., Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma, Cancer medicine, vol.6, pp.463-70, 2017.

H. Laklai, Y. A. Miroshnikova, M. W. Pickup, E. A. Collisson, G. E. Kim et al., Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression, Nat Med, vol.22, pp.497-505, 2016.

A. Albini, T. Florio, D. Giunciuglio, L. Masiello, S. Carlone et al., Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis, Faseb J, vol.13, pp.647-55, 1999.

S. Bonelli, X. Geeraerts, E. Bolli, J. Keirsse, M. Kiss et al., Beyond the M-CSF receptor -novel therapeutic targets in tumor-associated macrophages, FEBS J, vol.285, pp.777-87, 2018.

J. Xu, J. Escamilla, S. Mok, J. David, S. Priceman et al., CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer, Cancer Res, vol.73, pp.2782-94, 2013.

J. B. Mitchem, D. J. Brennan, B. L. Knolhoff, B. A. Belt, Y. Zhu et al., Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression, and improves chemotherapeutic responses, Cancer Res, vol.73, pp.1128-1169, 2013.

S. P. Pothula, Z. Xu, D. Goldstein, A. V. Biankin, R. C. Pirola et al., Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer, Br J Cancer, vol.114, pp.269-80, 2016.

D. F. Quail, R. L. Bowman, L. Akkari, M. L. Quick, A. J. Schuhmacher et al., The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas, Science, vol.352, p.3018, 2016.

A. Swierczak, A. D. Cook, J. C. Lenzo, C. M. Restall, J. P. Doherty et al., The promotion of breast cancer metastasis caused by inhibition of CSF-1R/CSF-1 signaling is blocked by targeting the G-CSF receptor, Cancer immunology research, vol.2, pp.765-76, 2014.

Y. Suleiman, A. Mahipal, D. Shibata, E. M. Siegel, H. Jump et al., Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer, Cancer Chemother Pharmacol, vol.76, pp.481-488, 2015.

M. Theodoropoulou and G. K. Stalla, Somatostatin receptors: from signaling to clinical practice, Front Neuroendocrinol, 2013.

A. A. Abdellatif, S. M. Aldalaen, W. Faisal, and H. M. Tawfeek, Somatostatin receptors as a new active targeting sites for nanoparticles, Saudi Pharmaceutical Journal, 2018.

R. L. Adams, I. P. Adams, S. W. Lindow, W. Zhong, and S. L. Atkin, Somatostatin receptors 2 and 5 are preferentially expressed in proliferating endothelium, Br. J. Cancer, vol.92, pp.1493-1498, 2005.

R. Afik, E. Zigmond, M. Vugman, M. Klepfish, E. Shimshoni et al., Tumor macrophages are pivotal constructors of tumor collagenous matrix, Journal of Experimental Medicine jem, 2016.

A. J. Aguirre, J. A. Nowak, N. D. Camarda, R. A. Moffitt, A. A. Ghazani et al., Real-time genomic characterization of advanced pancreatic cancer to enable precision medicine, Cancer Discovery CD, 2018.

A. Albini, T. Florio, D. Giunciuglio, L. Masiello, S. Carlone et al., Somatostatin controls Kaposi's sarcoma tumor growth through inhibition of angiogenesis, FASEB J, vol.13, pp.647-655, 1999.

J. Albrengues, T. Bertero, E. Grasset, S. Bonan, M. Maiel et al., Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts, Nat Commun, vol.6, p.10204, 2015.

B. Alemar, C. Gregório, and P. Ashton-prolla, miRNAs As Diagnostic and Prognostic Biomarkers in Pancreatic Ductal Adenocarcinoma and Its Precursor Lesions: A Review, vol.10, pp.113-124, 2015.

T. Alissafi, A. Hatzioannou, K. Mintzas, R. M. Barouni, A. Banos et al., Autophagy orchestrates the regulatory program of tumor-associated myeloid-derived suppressor cells, J. Clin. Invest, 2018.

R. Alvarez, M. Musteanu, E. Garcia-garcia, P. P. Lopez-casas, D. Megias et al., Stromal disrupting effects of nab-paclitaxel in pancreatic cancer, Br. J. Cancer, vol.109, pp.926-933, 2013.

A. Andoh, K. Hata, M. Shimada, S. Fujino, K. Tasaki et al., Inhibitory effects of somatostatin on tumor necrosis factor-alphainduced interleukin-6 secretion in human pancreatic periacinar myofibroblasts, Int. J. Mol. Med, vol.10, pp.89-93, 2002.

M. Antonyak, C. , and R. , Ras and the FAK Paradox, Molecular Cell, vol.35, pp.141-142, 2009.

M. Apte, R. Pirola, W. , and J. , The fibrosis of chronic pancreatitis: new insights into the role of pancreatic stellate cells, Antioxid. Redox Signal, vol.15, pp.2711-2722, 2011.

A. Vargas, F. Furness, A. J. Solomon, I. Joshi, K. Mekkaoui et al., Fc-Optimized Anti-CD25 Depletes Tumor-Infiltrating Regulatory T Cells and Synergizes with PD-1 Blockade to Eradicate Established Tumors, Immunity, vol.46, pp.577-586, 2017.

C. Armani, E. Catalani, A. Balbarini, P. Bagnoli, and D. Cervia, Expression, pharmacology, and functional role of somatostatin receptor subtypes 1 and 2 in human macrophages, J. Leukoc. Biol, vol.81, pp.845-855, 2007.

T. Armstrong, G. Packham, L. B. Murphy, A. C. Bateman, J. A. Conti et al., Type I collagen promotes the malignant phenotype of pancreatic ductal adenocarcinoma, Clin. Cancer Res, vol.10, pp.7427-7437, 2004.

Y. Attieh, A. G. Clark, C. Grass, S. Richon, M. Pocard et al., Cancer-associated fibroblasts lead tumor invasion through integrin-?3-dependent fibronectin assembly, J. Cell Biol, vol.216, pp.3509-3520, 2017.

M. Augsten, C. Hägglöf, E. Olsson, C. Stolz, P. Tsagozis et al., CXCL14 is an autocrine growth factor for fibroblasts and acts as a multi-modal stimulator of prostate tumor growth, Proc. Natl. Acad. Sci. U.S.A, vol.106, pp.3414-3419, 2009.

A. Bai, K. Meetze, N. Y. Vo, S. Kollipara, E. K. Mazsa et al., GP369, an FGFR2-IIIb-specific antibody, exhibits potent antitumor activity against human cancers driven by activated FGFR2 signaling, Cancer Res, vol.70, pp.7630-7639, 2010.

P. Bailey, D. K. Chang, K. Nones, A. L. Johns, A. Patch et al., Genomic analyses identify molecular subtypes of pancreatic cancer, Nature, vol.531, pp.47-52, 2016.

S. Banerjee, S. Modi, O. Mcginn, X. Zhao, V. Dudeja et al., Impaired Synthesis of Stromal Components in Response to Minnelide Improves Vascular Function, Drug Delivery, and Survival in Pancreatic Cancer, Clin. Cancer Res, vol.22, pp.415-425, 2016.

S. Bao, G. Ouyang, X. Bai, Z. Huang, C. Ma et al., Periostin potently promotes metastatic growth of colon cancer by augmenting cell survival via the Akt/PKB pathway, Cancer Cell, vol.5, pp.329-339, 2004.

J. Barbazán, L. Alonso-alconada, N. Elkhatib, S. Geraldo, V. Gurchenkov et al., Liver Metastasis Is Facilitated by the Adherence of Circulating Tumor Cells to Vascular Fibronectin Deposits, Cancer Res, vol.77, pp.3431-3441, 2017.

F. Barbieri, A. Pattarozzi, M. Gatti, C. Porcile, A. Bajetto et al., Somatostatin receptors 1, 2, and 5 cooperate in the somatostatin inhibition of C6 glioma cell proliferation in vitro via a phosphotyrosine phosphatase-eta-dependent inhibition of extracellularly regulated kinase-1/2, Endocrinology, vol.149, pp.4736-4746, 2008.

L. J. Bayne, G. L. Beatty, N. Jhala, C. E. Clark, A. D. Rhim et al., Tumor-derived granulocyte-macrophage colony-stimulating factor regulates myeloid inflammation and T cell immunity in pancreatic cancer, Cancer Cell, vol.21, pp.822-835, 2012.

G. L. Beatty, E. G. Chiorean, M. P. Fishman, B. Saboury, U. R. Teitelbaum et al., CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans, Science, vol.331, pp.1612-1616, 2011.

Q. Ben, X. Jin, J. Liu, X. Cai, F. Yuan et al., Periostin, a matrix specific protein, is associated with proliferation and invasion of pancreatic cancer, Oncol. Rep, vol.25, pp.709-716, 2011.

N. Benali, P. Cordelier, D. Calise, P. Pages, P. Rochaix et al., Inhibition of growth and metastatic progression of pancreatic carcinoma in hamster after somatostatin receptor subtype 2 (sst2) gene expression and administration of cytotoxic somatostatin analog AN-238, Proc. Natl. Acad. Sci. U.S.A, vol.97, pp.9180-9185, 2000.

G. Bergers, R. Brekken, G. Mcmahon, T. H. Vu, T. Itoh et al., Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis, Nat. Cell Biol, vol.2, pp.737-744, 2000.

C. Bettegowda, M. Sausen, R. J. Leary, I. Kinde, Y. Wang et al., Detection of circulating tumor DNA in earlyand late-stage human malignancies, Sci Transl Med, vol.6, pp.224-248, 2014.

M. K. Bhasin, K. Ndebele, O. Bucur, E. U. Yee, H. H. Otu et al., Meta-analysis of transcriptome data identifies a novel 5-gene pancreatic adenocarcinoma classifier, Oncotarget, vol.7, pp.23263-23281, 2016.

N. A. Bhowmick, A. Chytil, D. Plieth, A. E. Gorska, N. Dumont et al., TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia, Science, vol.303, pp.848-851, 2004.

S. F. Boj, C. Hwang, L. A. Baker, I. I. Chio, D. D. Engle et al., Organoid models of human and mouse ductal pancreatic cancer, Cell, vol.160, pp.324-338, 2015.

E. Bournazou and J. Bromberg, Targeting the tumor microenvironment, JAK-STAT, vol.2, 2013.

C. Bousquet, E. Puente, L. Buscail, N. Vaysse, and C. Susini, Antiproliferative effect of somatostatin and analogs, Chemotherapy, vol.47, issue.2, pp.30-39, 2001.

C. Bousquet, J. Guillermet-guibert, N. Saint-laurent, E. Archer-lahlou, F. Lopez et al., Direct binding of p85 to sst2 somatostatin receptor reveals a novel mechanism for inhibiting PI3K pathway, EMBO J, vol.25, pp.3943-3954, 2006.

A. Bouvier, Z. Uhry, V. Jooste, A. Drouillard, L. Remontet et al., Focus on an unusual rise in pancreatic cancer incidence in France, Int J Epidemiol, vol.46, pp.1764-1772, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01541663

J. R. Brahmer, S. S. Tykodi, L. Q. Chow, W. Hwu, S. L. Topalian et al., Safety and Activity of Anti-PD-L1 Antibody in Patients with Advanced Cancer, New England Journal of Medicine, vol.366, pp.2455-2465, 2012.

R. E. Brand, B. M. Nolen, H. J. Zeh, P. J. Allen, M. A. Eloubeidi et al., Serum Biomarker Panels for the Detection of Pancreatic Cancer, Clin Cancer Res, vol.17, pp.805-816, 2011.

P. Brazeau, W. Vale, R. Burgus, N. Ling, M. Butcher et al., , 1973.

, Hypothalamic polypeptide that inhibits the secretion of immunoreactive pituitary growth hormone, Science, vol.179, pp.77-79

J. Brooks, B. Fleischmann-mundt, N. Woller, J. Niemann, S. Ribback et al., Perioperative, Spatiotemporally Coordinated Activation of T and NK Cells Prevents Recurrence of Pancreatic Cancer, Cancer Res, vol.78, pp.475-488, 2018.

C. Bruns, I. Lewis, U. Briner, G. Meno-tetang, and G. Weckbecker, SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile, Eur. J. Endocrinol, vol.146, pp.707-716, 2002.

C. J. Bruns, M. T. Harbison, D. W. Davis, C. A. Portera, R. Tsan et al., Epidermal Growth Factor Receptor Blockade with C225 Plus Gemcitabine Results in Regression of Human Pancreatic Carcinoma Growing Orthotopically in Nude Mice by Antiangiogenic Mechanisms, p.14

A. M. Buchan, C. Lin, J. Choi, and D. L. Barber, Somatostatin, acting at receptor subtype 1, inhibits Rho activity, the assembly of actin stress fibers, and cell migration, J. Biol. Chem, vol.277, pp.28431-28438, 2002.

L. Buscail, N. Saint-laurent, E. Chastre, J. C. Vaillant, C. Gespach et al., Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer, Cancer Res, vol.56, pp.1823-1827, 1996.

F. Calvo, N. Ege, A. Grande-garcia, S. Hooper, R. P. Jenkins et al., Mechanotransduction and YAP-dependent matrix remodelling is required for the generation and maintenance of cancerassociated fibroblasts, Nat. Cell Biol, vol.15, pp.637-646, 2013.

P. J. Campbell, S. Yachida, L. J. Mudie, P. J. Stephens, E. D. Pleasance et al., The patterns and dynamics of genomic instability in metastatic pancreatic cancer, Nature, vol.467, pp.1109-1113, 2010.

J. B. Candido, J. P. Morton, P. Bailey, A. D. Campbell, S. A. Karim et al., CSF1R+ Macrophages Sustain Pancreatic Tumor Growth through T Cell Suppression and Maintenance of Key Gene Programs that Define the Squamous Subtype, Cell Rep, vol.23, pp.1448-1460, 2018.

A. R. Cantelmo, L. Conradi, A. Brajic, J. Goveia, J. Kalucka et al., Inhibition of the Glycolytic Activator PFKFB3 in Endothelium Induces Tumor Vessel Normalization, Impairs Metastasis, and Improves Chemotherapy, Cancer Cell, vol.30, pp.968-985, 2016.

C. Capparelli, C. Guido, D. Whitaker-menezes, G. Bonuccelli, R. Balliet et al., Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production, Cell Cycle, vol.11, pp.2285-2302, 2012.

T. Celià-terrassa and Y. Kang, Distinctive properties of metastasis-initiating cells, Genes Dev, vol.30, pp.892-908, 2016.

M. Chalabi, C. Duluc, P. Caron, D. Vezzosi, J. Guillermet-guibert et al., Somatostatin analogs: does pharmacology impact antitumor efficacy?, Trends Endocrinol. Metab, vol.25, pp.115-127, 2014.

M. Chalabi-dchar, S. Cassant-sourdy, C. Duluc, M. Fanjul, H. Lulka et al., Loss of Somatostatin Receptor Subtype 2 Promotes Growth of KRAS-Induced Pancreatic Tumors in Mice by Activating PI3K Signaling and Overexpression of CXCL16, Gastroenterology, vol.148, pp.1452-1465, 2015.
URL : https://hal.archives-ouvertes.fr/inserm-02472216

A. Chan, I. Prassas, A. Dimitromanolakis, R. Brand, S. Serra et al., Validation of biomarkers that complement CA19.9 in detecting early pancreatic cancer, Clin Cancer Res, vol.20, pp.5787-5795, 2014.

C. Chang, J. Qiu, D. O'sullivan, M. D. Buck, T. Noguchi et al., Metabolic Competition in the Tumor Microenvironment Is a Driver of Cancer Progression, Cell, vol.162, pp.1229-1241, 2015.

V. P. Chauhan, J. D. Martin, H. Liu, D. A. Lacorre, S. R. Jain et al., Angiotensin inhibition enhances drug delivery and potentiates chemotherapy by decompressing tumour blood vessels, Nat Commun, vol.4, p.2516, 2013.

S. P. Che, J. Y. Park, and T. Stokol, Tissue Factor-Expressing Tumor-Derived Extracellular Vesicles Activate Quiescent Endothelial Cells via Protease-Activated Receptor, 2017.

, Front Oncol, vol.7, p.261

J. Chen, Z. Chen, M. Chen, D. Li, Z. Li et al., Role of fibrillar Tenascin-C in metastatic pancreatic cancer, Int. J. Oncol, vol.34, pp.1029-1036, 2009.

W. Chen, C. Ho, Y. Chang, H. Chen, C. Lin et al., Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling, Nat Commun, vol.5, p.3472, 2014.

Y. Chen, V. S. Lebleu, J. L. Carstens, H. Sugimoto, X. Zheng et al., Dual reporter genetic mouse models of pancreatic cancer identify an epithelial-to-mesenchymal transition-independent metastasis program, EMBO Mol Med, 2018.

L. Chéry, H. Lam, I. Coleman, B. Lakely, R. Coleman et al., Characterization of single disseminated prostate cancer cells reveals tumor cell heterogeneity and identifies dormancy associated pathways, Oncotarget, vol.5, pp.9939-9951, 2014.

C. L. Chew, A. Lunardi, F. Gulluni, D. T. Ruan, M. Chen et al., In vivo role of INPP4B in tumor and metastasis suppression through regulation of PI3K/AKT signaling at endosomes, Cancer Discov, vol.5, pp.740-751, 2015.

S. P. Chiang, R. M. Cabrera, and J. E. Segall, Tumor cell intravasation, Am J Physiol Cell Physiol, vol.311, pp.1-14, 2016.

E. J. Childs, E. Mocci, D. Campa, P. M. Bracci, S. Gallinger et al., Common variation at 2p13.3, 3q29, 7p13 and 17q25.1 associated with susceptibility to pancreatic cancer, Nat Genet, vol.47, pp.911-916, 2015.

T. Chinen, A. K. Kannan, A. G. Levine, X. Fan, U. Klein et al., An essential role for the IL-2 receptor in Treg cell function, Nat. Immunol, vol.17, pp.1322-1333, 2016.

E. G. Chiorean, B. P. Schneider, F. M. Akisik, S. M. Perkins, S. Anderson et al., Phase 1 pharmacogenetic and pharmacodynamic study of sorafenib with concurrent radiation therapy and gemcitabine in locally advanced unresectable pancreatic cancer, Int. J. Radiat. Oncol. Biol. Phys, vol.89, pp.284-291, 2014.

D. K. Chiu, .. Tse, A. P. , .. Xu, I. M. et al., Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma, Nat Commun, vol.8, p.517, 2017.

M. Chmielewski, O. Hahn, G. Rappl, M. Nowak, I. H. Schmidt-wolf et al., T cells that target carcinoembryonic antigen eradicate orthotopic pancreatic carcinomas without inducing autoimmune colitis in mice, Gastroenterology, vol.143, pp.1095-1107, 2012.

A. Chronopoulos, B. Robinson, M. Sarper, E. Cortes, V. Auernheimer et al., ATRA mechanically reprograms pancreatic stellate cells to suppress matrix remodelling and inhibit cancer cell invasion, Nat Commun, vol.7, p.12630, 2016.

S. B. Coffelt, K. Kersten, C. W. Doornebal, J. Weiden, K. Vrijland et al., IL-17-producing ?? T cells and neutrophils conspire to promote breast cancer metastasis, Nature, vol.522, pp.345-348, 2015.

J. D. Cohen, A. A. Javed, C. Thoburn, F. Wong, J. Tie et al., Combined circulating tumor DNA and protein biomarker-based liquid biopsy for the earlier detection of pancreatic cancers, Proc. Natl. Acad. Sci. U.S.A, vol.114, pp.10202-10207, 2017.

E. A. Collisson, A. Sadanandam, P. Olson, W. J. Gibb, M. Truitt et al., Subtypes of Pancreatic Ductal Adenocarcinoma and Their Differing Responses to Therapy, Nat Med, vol.17, pp.500-503, 2011.

A. Costa, Y. Kieffer, A. Scholer-dahirel, F. Pelon, B. Bourachot et al., Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer, Cancer Cell, vol.33, pp.463-479, 2018.
URL : https://hal.archives-ouvertes.fr/inserm-02437793

B. Costa-silva, N. M. Aiello, A. J. Ocean, S. Singh, H. Zhang et al., Pancreatic cancer exosomes initiate premetastatic niche formation in the liver, Nat. Cell Biol, vol.17, pp.816-826, 2015.

G. A. Cote, A. J. Gore, S. D. Mcelyea, L. E. Heathers, H. Xu et al., A pilot study to develop a diagnostic test for pancreatic ductal adenocarcinoma based on differential expression of select miRNA in plasma and bile, Am. J. Gastroenterol, vol.109, pp.1942-1952, 2014.

J. Cros, J. Raffenne, A. Couvelard, and N. Poté, Tumor Heterogeneity in Pancreatic Adenocarcinoma, Pathobiology, vol.85, pp.64-71, 2018.

T. J. Curiel, G. Coukos, L. Zou, X. Alvarez, P. Cheng et al., Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival, Nat. Med, vol.10, pp.942-949, 2004.

M. Curtis, H. A. Kenny, B. Ashcroft, A. Mukherjee, A. Johnson et al., Fibroblasts Mobilize Tumor Cell Glycogen to Promote Proliferation and Metastasis, Cell Metab, 2018.

V. A. Dalm, P. M. Van-hagen, P. M. Van-koetsveld, S. Achilefu, A. B. Houtsmuller et al., Expression of somatostatin, cortistatin, and somatostatin receptors in human monocytes, macrophages, and dendritic cells, Am. J. Physiol. Endocrinol. Metab, vol.285, pp.344-353, 2003.

A. Dasgupta, A. R. Lim, and C. M. Ghajar, Circulating and disseminated tumor cells: harbingers or initiators of metastasis?, Mol Oncol, vol.11, pp.40-61, 2017.

P. Dauer, X. Zhao, V. K. Gupta, N. Sharma, K. Kesh et al., Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression, Cancer Res, vol.78, pp.1321-1333, 2018.

Z. D'costa, K. Jones, A. Azad, R. Van-stiphout, S. Y. Lim et al., Gemcitabine-Induced TIMP1 Attenuates Therapy Response and Promotes Tumor Growth and Liver Metastasis in Pancreatic Cancer, Cancer Research, vol.77, pp.5952-5962, 2017.

O. De-henau, M. Rausch, D. Winkler, L. F. Campesato, C. Liu et al., Overcoming resistance to checkpoint blockade therapy by targeting PI3K? in myeloid cells, Nature, vol.539, pp.443-447, 2016.

L. De-monte, M. Reni, E. Tassi, D. Clavenna, I. Papa et al., Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer, J. Exp. Med, vol.208, pp.469-478, 2011.

E. L. Deer, J. González-hernández, J. D. Coursen, J. E. Shea, J. Ngatia et al., Phenotype and genotype of pancreatic cancer cell lines, Pancreas, vol.39, pp.425-435, 2010.

G. M. Delgoffe, S. Woo, M. E. Turnis, D. M. Gravano, C. Guy et al., Stability and function of regulatory T cells is maintained by a neuropilin-1-semaphorin-4a axis, Nature, vol.501, pp.252-256, 2013.

D. Delitto, K. Pham, A. C. Vlada, G. A. Sarosi, R. M. Thomas et al., Patient-derived xenograft models for pancreatic adenocarcinoma demonstrate retention of tumor morphology through incorporation of murine stromal elements, Am. J. Pathol, vol.185, pp.1297-1303, 2015.

G. M. Denicola, F. A. Karreth, T. J. Humpton, A. Gopinathan, C. Wei et al., Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis, Nature, vol.475, pp.106-109, 2011.

E. I. Deryugina and W. B. Kiosses, Intratumoral Cancer Cell Intravasation Can Occur Independent of Invasion into the Adjacent Stroma, Cell Rep, vol.19, pp.601-616, 2017.

V. M. Díaz, J. Planaguma, T. M. Thomson, J. Reventós, and R. Paciucci, Tissue plasminogen activator is required for the growth, invasion, and angiogenesis of pancreatic tumor cells, Gastroenterology, vol.122, pp.806-819, 2002.

F. Diehl, K. Schmidt, M. A. Choti, K. Romans, S. Goodman et al., Circulating mutant DNA to assess tumor dynamics, Nature Medicine, vol.14, pp.985-990, 2008.

M. Djurec, O. Graña, A. Lee, K. Troulé, E. Espinet et al., Saa3 is a key mediator of the protumorigenic properties of cancer-associated fibroblasts in pancreatic tumors, Proc. Natl. Acad. Sci. U.S.A, vol.115, pp.1147-1156, 2018.

Y. V. Dobrynin, Establishment and Characteristics of Cell Strains From Some Epithelial Tumors of Human Origin, J Natl Cancer Inst, vol.31, pp.1173-1195, 1963.

S. K. Donnelly, R. Cabrera, S. P. Mao, J. R. Christin, B. Wu et al., Rac3 regulates breast cancer invasion and metastasis by controlling adhesion and matrix degradation, J. Cell Biol, vol.216, pp.4331-4349, 2017.

C. Duluc, S. Moatassim-billah, M. Chalabi-dchar, A. Perraud, R. Samain et al., Pharmacological targeting of the protein synthesis mTOR/4E-BP1 pathway in cancerassociated fibroblasts abrogates pancreatic tumour chemoresistance, EMBO Mol Med, vol.7, pp.735-753, 2015.
URL : https://hal.archives-ouvertes.fr/hal-02421448

H. Duong, J. S. Hwang, H. J. Kim, H. J. Kang, Y. Seong et al., Aldehyde dehydrogenase 1A1 confers intrinsic and acquired resistance to gemcitabine in human pancreatic adenocarcinoma MIA PaCa-2 cells, Int. J. Oncol, vol.41, pp.855-861, 2012.

D. E. Elliott, J. Li, A. M. Blum, A. Metwali, Y. C. Patel et al., , 1999.

, SSTR2A is the dominant somatostatin receptor subtype expressed by inflammatory cells, is widely expressed and directly regulates T cell IFN-gamma release, Eur. J. Immunol, vol.29, pp.2454-2463

A. Ene-obong, A. J. Clear, J. Watt, J. Wang, R. Fatah et al., Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma, Gastroenterology, vol.145, pp.1121-1132, 2013.

B. Erdogan, M. Ao, L. M. White, A. L. Means, B. M. Brewer et al., Cancer-associated fibroblasts promote directional cancer cell migration by aligning fibronectin, J. Cell Biol, vol.216, pp.3799-3816, 2017.

N. Erez, M. Truitt, P. Olson, S. T. Arron, and D. Hanahan, Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner, Cancer Cell, vol.17, pp.135-147, 2010.

J. T. Erler, K. L. Bennewith, M. Nicolau, N. Dornhöfer, C. Kong et al., Lysyl oxidase is essential for hypoxia-induced metastasis, Nature, vol.440, pp.1222-1226, 2006.

J. T. Erler, K. L. Bennewith, T. R. Cox, G. Lang, D. Bird et al., Hypoxia-induced lysyl oxidase is a critical mediator of bone marrow cell recruitment to form the premetastatic niche, Cancer Cell, vol.15, pp.35-44, 2009.

B. Farrow, D. H. Berger, and D. Rowley, Tumor-derived pancreatic stellate cells promote pancreatic cancer cell invasion through release of thrombospondin-2, J. Surg. Res, vol.156, pp.155-160, 2009.

C. Feig, J. O. Jones, M. Kraman, R. J. Wells, A. Deonarine et al., Targeting CXCL12 from FAPexpressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer, Proc. Natl. Acad. Sci. U.S.A, vol.110, pp.20212-20217, 2013.

M. E. Feigin and D. A. Tuveson, Challenges and Opportunities in Modeling Pancreatic Cancer, Cold Spring Harb. Symp. Quant. Biol, vol.81, pp.231-235, 2016.

I. J. Fidler, The pathogenesis of cancer metastasis: the "seed and soil" hypothesis revisited, Nat. Rev. Cancer, vol.3, pp.453-458, 2003.

K. R. Fischer, A. Durrans, S. Lee, J. Sheng, F. Li et al., Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance, Nature, vol.527, pp.472-476, 2015.

M. Y. Fong, W. Zhou, L. Liu, A. Y. Alontaga, M. Chandra et al., Breast-cancer-secreted miR-122 reprograms glucose metabolism in premetastatic niche to promote metastasis, Nat. Cell Biol, vol.17, pp.183-194, 2015.

J. D. Fontenot, M. A. Gavin, and A. Y. Rudensky, Foxp3 programs the development and function of CD4+CD25+ regulatory T cells, Nat. Immunol, vol.4, pp.330-336, 2003.

A. E. Frampton, M. M. Prado, E. López-jiménez, A. B. Fajardo-puerta, Z. A. Jawad et al., Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden, Oncotarget, vol.9, pp.19006-19013, 2018.

G. Francia, W. Cruz-munoz, S. Man, P. Xu, and R. S. Kerbel, Mouse models of advanced spontaneous metastasis for experimental therapeutics, Nat. Rev. Cancer, vol.11, pp.135-141, 2011.

C. Fremd, F. Schuetz, C. Sohn, P. Beckhove, and C. Domschke, B cell-regulated immune responses in tumor models and cancer patients, Oncoimmunology, vol.2, p.25443, 2013.

K. K. Frese, A. Neesse, N. Cook, T. E. Bapiro, M. P. Lolkema et al., nab-Paclitaxel potentiates gemcitabine activity by reducing cytidine deaminase levels in a mouse model of pancreatic cancer, Cancer Discov, vol.2, pp.260-269, 2012.

P. Friedl and K. Wolf, Proteolytic interstitial cell migration: a five-step process, Cancer Metastasis Rev, vol.28, pp.129-135, 2009.

J. C. Friedland, M. H. Lee, and D. Boettiger, Mechanically activated integrin switch controls alpha5beta1 function, Science, vol.323, pp.642-644, 2009.

F. E. Froeling, C. Feig, C. Chelala, R. Dobson, C. E. Mein et al., Retinoic Acid-Induced Pancreatic Stellate Cell Quiescence Reduces Paracrine Wnt-?-Catenin Signaling to Slow Tumor Progression, Gastroenterology, vol.141, pp.1486-1497, 2011.

A. Fu, S. Ma, N. Wei, B. X. Tan, E. Y. Tan et al., High expression of MnSOD promotes survival of circulating breast cancer cells and increases their resistance to doxorubicin, Oncotarget, vol.7, pp.50239-50257, 2016.

Y. Fu, Y. Lai, Q. Wang, X. Liu, W. He et al., , 2013.

, Overexpression of clusterin promotes angiogenesis via the vascular endothelial growth factor in primary ovarian cancer, Mol Med Rep, vol.7, pp.1726-1732

A. Fukuda, S. C. Wang, J. P. Morris, A. E. Folias, A. Liou et al., Stat3 and MMP7 Contribute to Pancreatic Ductal Adenocarcinoma Initiation and Progression, Cancer Cell, vol.19, pp.441-455, 2011.

A. Fukunaga, M. Miyamoto, Y. Cho, S. Murakami, Y. Kawarada et al., CD8+ tumor-infiltrating lymphocytes together with CD4+ tumor-infiltrating lymphocytes and dendritic cells improve the prognosis of patients with pancreatic adenocarcinoma, Pancreas, vol.28, pp.26-31, 2004.

E. Gadaleta, R. J. Cutts, G. P. Kelly, T. Crnogorac-jurcevic, H. M. Kocher et al., A global insight into a cancer transcriptional space using pancreatic data: importance, findings and flaws, Nucleic Acids Res, vol.39, pp.7900-7907, 2011.

C. Gaggioli, S. Hooper, C. Hidalgo-carcedo, R. Grosse, J. F. Marshall et al., Fibroblast-led collective invasion of carcinoma cells with differing roles for RhoGTPases in leading and following cells, Nat. Cell Biol, vol.9, pp.1392-1400, 2007.

L. Gailhouste, L. C. Liew, I. Hatada, H. Nakagama, and T. Ochiya, Epigenetic reprogramming using 5-azacytidine promotes an anti-cancer response in pancreatic adenocarcinoma cells, Cell Death Dis, vol.9, p.468, 2018.

J. Galon, A. Costes, F. Sanchez-cabo, A. Kirilovsky, B. Mlecnik et al., Type, density, and location of immune cells within human colorectal tumors predict clinical outcome, Science, vol.313, pp.1960-1964, 2006.

H. Gao, J. M. Korn, S. Ferretti, J. E. Monahan, Y. Wang et al., High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response, Nat. Med, vol.21, pp.1318-1325, 2015.

N. Gengenbacher, M. Singhal, A. , and H. G. , Preclinical mouse solid tumour models: status quo, challenges and perspectives, Nature Reviews Cancer, vol.17, pp.751-765, 2017.

T. Ghansah, N. Vohra, K. Kinney, A. Weber, K. Kodumudi et al., Dendritic cell immunotherapy combined with gemcitabine chemotherapy enhances survival in a murine model of pancreatic carcinoma, Cancer Immunol. Immunother, vol.62, pp.1083-1091, 2013.

E. Giovannetti, C. L. Van-der-borden, A. E. Frampton, A. Ali, O. Firuzi et al., Never let it go: Stopping key mechanisms underlying metastasis to fight pancreatic cancer, Seminars in Cancer Biology, vol.44, pp.43-59, 2017.

N. Gjorevski, N. Sachs, A. Manfrin, S. Giger, M. E. Bragina et al., Designer matrices for intestinal stem cell and organoid culture, Nature, vol.539, pp.560-564, 2016.

A. Glentis, P. Oertle, P. Mariani, A. Chikina, F. El-marjou et al., Cancer-associated fibroblasts induce metalloproteaseindependent cancer cell invasion of the basement membrane, Nat Commun, vol.8, p.924, 2017.

A. Gopinathan, J. P. Morton, D. I. Jodrell, and O. J. Sansom, GEMMs as preclinical models for testing pancreatic cancer therapies, Disease Models & Mechanisms, vol.8, pp.1185-1200, 2015.

S. Goswami, E. Sahai, J. B. Wyckoff, M. Cammer, D. Cox et al., Macrophages promote the invasion of breast carcinoma cells via a colony-stimulating factor-1/epidermal growth factor paracrine loop, Cancer Res, vol.65, pp.5278-5283, 2005.

E. M. Grasset, T. Bertero, A. Bozec, J. Friard, I. Bourget et al., Matrix stiffening and EGFR cooperate to promote the collective invasion of cancer cells, Cancer Res, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02347409

Y. Grinberg-bleyer, H. Oh, A. Desrichard, D. M. Bhatt, R. Caron et al., NF-?B c-Rel Is Crucial for the Regulatory T Cell Immune Checkpoint in Cancer, Cell, vol.170, pp.1096-1108, 2017.

S. Grozinsky-glasberg, I. Shimon, M. Korbonits, and A. B. Grossman, Somatostatin analogues in the control of neuroendocrine tumours: efficacy and mechanisms, Endocr. Relat. Cancer, vol.15, pp.701-720, 2008.

B. Grünwald, V. Harant, S. Schaten, M. Frühschütz, R. Spallek et al., Pancreatic Premalignant Lesions Secrete Tissue Inhibitor of Metalloproteinases-1, Which Activates Hepatic Stellate Cells Via CD63 Signaling to Create a Premetastatic Niche in the Liver, Gastroenterology, vol.151, pp.1011-1024, 2016.

J. J. Grzesiak and M. Bouvet, The alpha2beta1 integrin mediates the malignant phenotype on type I collagen in pancreatic cancer cell lines, Br. J. Cancer, vol.94, pp.1311-1319, 2006.

J. J. Grzesiak, K. C. Smith, D. W. Burton, L. J. Deftos, and M. Bouvet, Integrinmediated laminin-1 adhesion upregulates CXCR4 and IL-8 expression in pancreatic cancer cells, Surgery, vol.141, pp.804-814, 2007.

J. Guan, H. Zhang, Z. Wen, Y. Gu, Y. Cheng et al., Retinoic acid inhibits pancreatic cancer cell migration and EMT through the downregulation of IL-6 in cancer associated fibroblast cells, Cancer Lett, vol.345, pp.132-139, 2014.

R. Guillemin, Somatostatin: the beginnings, 1972, Mol. Cell. Endocrinol, vol.286, pp.3-4, 2008.

J. Guillermet, N. Saint-laurent, P. Rochaix, O. Cuvillier, T. Levade et al., Somatostatin receptor subtype 2 sensitizes human pancreatic cancer cells to death ligand-induced apoptosis, Proc. Natl. Acad. Sci. U.S.A, vol.100, pp.155-160, 2003.

J. Guillermet-guibert, H. Lahlou, P. Cordelier, C. Bousquet, S. Pyronnet et al., Physiology of somatostatin receptors, J. Endocrinol. Invest, vol.28, pp.5-9, 2005.

D. G. Hackam and D. A. Redelmeier, Translation of Research Evidence From Animals to Humans, JAMA, vol.296, p.1727, 2006.

P. M. Hagen, V. A. Dalm, F. Staal, and L. J. Hofland, The role of cortistatin in the human immune system, Mol. Cell. Endocrinol, vol.286, pp.141-147, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00532017

L. Hakanpaa, T. Sipila, V. Leppanen, P. Gautam, H. Nurmi et al., Endothelial destabilization by angiopoietin-2 via integrin ?1 activation, Nature Communications, vol.6, p.5962, 2015.

D. A. Harrison, The JAK/STAT Pathway, Cold Spring Harbor Perspectives in Biology, vol.4, pp.11205-011205, 2012.

K. B. Heiden, A. J. Williamson, M. E. Doscas, J. Ye, Y. Wang et al., The sonic hedgehog signaling pathway maintains the cancer stem cell self-renewal of anaplastic thyroid cancer by inducing snail expression, J. Clin. Endocrinol. Metab, vol.99, pp.2178-2187, 2014.

P. C. Hermann, S. L. Huber, T. Herrler, A. Aicher, J. W. Ellwart et al., Distinct populations of cancer stem cells determine tumor growth and metastatic activity in human pancreatic cancer, Cell Stem Cell, vol.1, pp.313-323, 2007.

E. Hessmann, M. S. Patzak, L. Klein, N. Chen, V. Kari et al., Fibroblast drug scavenging increases intratumoural gemcitabine accumulation in murine pancreas cancer, 2017.

A. F. Hezel, A. C. Kimmelman, B. Z. Stanger, N. Bardeesy, and R. A. Depinho, , 2006.

, Genetics and biology of pancreatic ductal adenocarcinoma, Genes Dev, vol.20, pp.1218-1249

M. Hidalgo, F. Amant, A. V. Biankin, E. Budinska, A. T. Byrne et al., Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research, Cancer Discovery, vol.4, pp.998-1013, 2014.

S. R. Hingorani and J. D. Potter, Pancreas Cancer Meets the Thunder God, Science Translational Medicine, vol.4, pp.156-177, 2012.

S. R. Hingorani, E. F. Iii, A. Maitra, V. Rajapakse, C. King et al., Preinvasive and invasive ductal pancreatic cancer and its early detection in the mouse, CANCER CELL, vol.14, 2003.

S. R. Hingorani, L. Wang, A. S. Multani, C. Combs, T. B. Deramaudt et al., Trp53R172H and KrasG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice, Cancer Cell, vol.7, pp.469-483, 2005.

N. Hiraoka, K. Onozato, T. Kosuge, and S. Hirohashi, Prevalence of FOXP3+ regulatory T cells increases during the progression of pancreatic ductal adenocarcinoma and its premalignant lesions, Clin. Cancer Res, vol.12, pp.5423-5434, 2006.

S. Hiratsuka, K. Nakamura, S. Iwai, M. Murakami, T. Itoh et al., MMP9 induction by vascular endothelial growth factor receptor-1 is involved in lung-specific metastasis, Cancer Cell, vol.2, pp.289-300, 2002.

S. Hiratsuka, A. Watanabe, H. Aburatani, and Y. Maru, Tumour-mediated upregulation of chemoattractants and recruitment of myeloid cells predetermines lung metastasis, Nat. Cell Biol, vol.8, pp.1369-1375, 2006.

A. Hoshino, B. Costa-silva, T. Shen, G. Rodrigues, A. Hashimoto et al., Tumour exosome integrins determine organotropic metastasis, Nature, vol.527, pp.329-335, 2015.

C. Huang, N. Li, Z. Li, A. Chang, Y. Chen et al., Tumour-derived Interleukin 35 promotes pancreatic ductal adenocarcinoma cell extravasation and metastasis by inducing ICAM1 expression, Nat Commun, vol.8, 2017.

G. Huang, G. Ge, V. Izzi, and D. S. Greenspan, ?3 Chains of type V collagen regulate breast tumour growth via glypican-1, Nat Commun, vol.8, p.14351, 2017.

L. Huang, A. Holtzinger, I. Jagan, M. Begora, I. Lohse et al., Ductal pancreatic cancer modeling and drug screening using human pluripotent stem cell and patient-derived tumor organoids, Nat Med, vol.21, pp.1364-1371, 2015.

Q. Huang, M. Huang, F. Meng, and R. Sun, Activated pancreatic stellate cells inhibit NK cell function in the human pancreatic cancer microenvironment, Cellular & Molecular Immunology, vol.1, 2018.

Q. Huang, X. Hu, W. He, Y. Zhao, S. Hao et al., Fluid shear stress and tumor metastasis, Am J Cancer Res, vol.8, pp.763-777, 2018.

W. Huanwen, L. Zhiyong, S. Xiaohua, R. Xinyu, W. Kai et al., , 2009.

, Intrinsic chemoresistance to gemcitabine is associated with constitutive and laminin-induced phosphorylation of FAK in pancreatic cancer cell lines, Mol. Cancer, vol.8, p.125

J. Huelsken and D. Hanahan, A Subset of Cancer-Associated Fibroblasts Determines Therapy Resistance, Cell, vol.172, pp.643-644, 2018.

J. Hulit, K. Suyama, S. Chung, R. Keren, G. Agiostratidou et al., N-cadherin signaling potentiates mammary tumor metastasis via enhanced extracellular signal-regulated kinase activation, Cancer Res, vol.67, pp.3106-3116, 2007.

C. Hwang, S. F. Boj, H. Clevers, and D. A. Tuveson, Pre-clinical Models of Pancreatic Ductal Adenocarcinoma, J Pathol, vol.238, pp.197-204, 2016.

R. F. Hwang, T. T. Moore, M. M. Hattersley, M. Scarpitti, B. Yang et al., Inhibition of the hedgehog pathway targets the tumor-associated stroma in pancreatic cancer, Mol. Cancer Res, vol.10, pp.1147-1157, 2012.

C. S. Ilkow, M. Marguerie, C. Batenchuk, J. Mayer, D. Ben-neriah et al., Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity, Nat. Med, vol.21, pp.530-536, 2015.

J. R. Infante, B. G. Somer, J. O. Park, C. Li, M. E. Scheulen et al., A randomised, double-blind, placebocontrolled trial of trametinib, an oral MEK inhibitor, in combination with gemcitabine for patients with untreated metastatic adenocarcinoma of the pancreas, Eur. J. Cancer, vol.50, pp.2072-2081, 2014.

K. S. Inman, A. A. Francis, and N. R. Murray, Complex role for the immune system in initiation and progression of pancreatic cancer, World J Gastroenterol, vol.20, pp.11160-11181, 2014.

M. A. Jacobetz, D. S. Chan, A. Neesse, T. E. Bapiro, N. Cook et al., Hyaluronan impairs vascular function and drug delivery in a mouse model of pancreatic cancer, Gut, vol.62, pp.112-120, 2013.

C. Jean, X. L. Chen, J. Nam, I. Tancioni, S. Uryu et al., Inhibition of endothelial FAK activity prevents tumor metastasis by enhancing barrier function, J. Cell Biol, vol.204, pp.247-263, 2014.

H. Jiang, S. Hegde, B. L. Knolhoff, Y. Zhu, J. M. Herndon et al., Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy, Nat. Med, 2016.

W. G. Jiang, A. J. Sanders, M. Katoh, H. Ungefroren, F. Gieseler et al., Tissue invasion and metastasis: Molecular, biological and clinical perspectives, Seminars in Cancer Biology, vol.35, pp.244-275, 2015.

J. I. Johnson, S. Decker, D. Zaharevitz, L. V. Rubinstein, J. M. Venditti et al., Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials, Br J Cancer, vol.84, pp.1424-1431, 2001.

S. Jones, X. Zhang, D. W. Parsons, J. Lin, R. J. Leary et al., Core signaling pathways in human pancreatic cancers revealed by global genomic analyses, Science, vol.321, pp.1801-1806, 2008.

J. Jung, C. H. Lee, H. S. Seol, Y. S. Choi, E. Kim et al., Generation and molecular characterization of pancreatic cancer patient-derived xenografts reveals their heterologous nature, Oncotarget, vol.7, pp.62533-62546, 2016.

P. Jurasz, D. Alonso-escolano, and M. W. Radomski, Platelet-cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation, Br J Pharmacol, vol.143, pp.819-826, 2004.

M. Kalli and T. Stylianopoulos, Defining the Role of Solid Stress and Matrix Stiffness in Cancer Cell Proliferation and Metastasis, Front Oncol, vol.8, 2018.

R. Kalluri, The biology and function of fibroblasts in cancer, Nature Reviews Cancer, vol.16, pp.582-598, 2016.

M. M. Kaneda, P. Cappello, A. V. Nguyen, N. Ralainirina, C. R. Hardamon et al., Macrophage PI3K? drives pancreatic ductal adenocarcinoma progression, 2016.

M. M. Kaneda, K. S. Messer, N. Ralainirina, H. Li, C. J. Leem et al., PI3K? is a molecular switch that controls immune suppression, Nature, vol.539, pp.437-442, 2016.

A. Karki, S. E. Humphrey, R. E. Steele, D. A. Hess, E. J. Taparowsky et al., Silencing Mist1 Gene Expression Is Essential for Recovery from Acute Pancreatitis, PLoS ONE, vol.10, 2015.

A. K. Karlsson and S. N. Saleh, Checkpoint inhibitors for malignant melanoma: a systematic review and meta-analysis, Clin Cosmet Investig Dermatol, vol.10, pp.325-339, 2017.

O. Kawai, G. Ishii, K. Kubota, Y. Murata, Y. Naito et al., Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer, Cancer, vol.113, pp.1387-1395, 2008.

S. Khuon, L. Liang, R. W. Dettman, P. H. Sporn, R. B. Wysolmerski et al.,

, Myosin light chain kinase mediates transcellular intravasation of breast cancer cells through the underlying endothelial cells: a three-dimensional FRET study, J. Cell. Sci, vol.123, pp.431-440

S. Kim, H. Takahashi, W. Lin, P. Descargues, S. Grivennikov et al., Carcinoma-produced factors activate myeloid cells through TLR2 to stimulate metastasis, Nature, vol.457, pp.102-106, 2009.

K. Koikawa, K. Ohuchida, Y. Ando, S. Kibe, H. Nakayama et al., Basement membrane destruction by pancreatic stellate cells leads to local invasion in pancreatic ductal adenocarcinoma, Cancer Lett, vol.425, pp.65-77, 2018.

Y. Kojima, A. Acar, E. N. Eaton, K. T. Mellody, C. Scheel et al., Autocrine TGF-? and stromal cellderived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts, MEDICAL SCIENCES, vol.6

J. Köninger, N. A. Giese, F. F. Di-mola, P. Berberat, T. Giese et al., Overexpressed decorin in pancreatic cancer: potential tumor growth inhibition and attenuation of chemotherapeutic action, Clin. Cancer Res, vol.10, pp.4776-4783, 2004.

S. Kordes, H. J. Klümpen, M. J. Weterman, J. H. Schellens, D. J. Richel et al., Phase II study of capecitabine and the oral mTOR inhibitor everolimus in patients with advanced pancreatic cancer, Cancer Chemother. Pharmacol, vol.75, pp.1135-1141, 2015.

G. Kou, J. Shi, L. Chen, D. Zhang, S. Hou et al., A bispecific antibody effectively inhibits tumor growth and metastasis by simultaneous blocking vascular endothelial growth factor A and osteopontin, Cancer Lett, vol.299, pp.130-136, 2010.

M. Kraman, P. J. Bambrough, J. N. Arnold, E. W. Roberts, L. Magiera et al., Suppression of antitumor immunity by stromal cells expressing fibroblast activation protein-alpha, Science, vol.330, pp.827-830, 2010.

A. M. Krebs, J. Mitschke, M. Lasierra-losada, O. Schmalhofer, M. Boerries et al., The EMTactivator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer, Nat. Cell Biol, vol.19, pp.518-529, 2017.

B. D. Krempley, Y. , and K. H. , Preclinical models of pancreatic ductal adenocarcinoma, Chinese Clinical Oncology, vol.6, 2017.

Y. Kubota, K. Takubo, T. Shimizu, H. Ohno, K. Kishi et al., M-CSF inhibition selectively targets pathological angiogenesis and lymphangiogenesis, J. Exp. Med, vol.206, pp.1089-1102, 2009.

A. Kuchnio, S. Moens, U. Bruning, K. Kuchnio, B. Cruys et al., The Cancer Cell Oxygen Sensor PHD2 Promotes Metastasis via Activation of Cancer-Associated Fibroblasts, Cell Rep, vol.12, pp.992-1005, 2015.

U. Kumar and M. Grant, Somatostatin and somatostatin receptors, Results Probl Cell Differ, vol.50, pp.137-184, 2010.

V. Kumar, L. Donthireddy, D. Marvel, T. Condamine, F. Wang et al., Cancer-Associated Fibroblasts Neutralize the Anti-tumor Effect of CSF1 Receptor Blockade by Inducing PMN-MDSC Infiltration of Tumors, Cancer Cell, vol.32, pp.654-668, 2017.

X. Lai, M. Wang, S. D. Mcelyea, S. Sherman, M. House et al., A microRNA signature in circulating exosomes is superior to exosomal glypican-1 levels for diagnosing pancreatic cancer, Cancer Lett, vol.393, pp.86-93, 2017.

M. A. Lakins, E. Ghorani, H. Munir, C. P. Martins, and J. D. Shields, Cancerassociated fibroblasts induce antigen-specific deletion of CD8 + T Cells to protect tumour cells, Nat Commun, vol.9, p.948, 2018.

H. Laklai, S. Laval, L. Dumartin, P. Rochaix, M. Hagedorn et al., Thrombospondin-1 is a critical effector of oncosuppressive activity of sst2 somatostatin receptor on pancreatic cancer, Proc. Natl. Acad. Sci. U.S.A, vol.106, pp.17769-17774, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00504705

H. Laklai, Y. A. Miroshnikova, M. W. Pickup, E. A. Collisson, G. E. Kim et al., Genotype tunes pancreatic ductal adenocarcinoma tissue tension to induce matricellular fibrosis and tumor progression, Nat. Med, vol.22, pp.497-505, 2016.

D. Lambrechts, E. Wauters, B. Boeckx, S. Aibar, D. Nittner et al., Phenotype molding of stromal cells in the lung tumor microenvironment, Nature Medicine, 2018.

D. Laoui, E. Van-overmeire, P. De-baetselier, J. A. Van-ginderachter, and G. Raes, Functional Relationship between Tumor-Associated Macrophages and Macrophage Colony-Stimulating Factor as Contributors to Cancer Progression, Front Immunol, vol.5, p.489, 2014.

D. T. Le, E. Lutz, J. N. Uram, E. A. Sugar, B. Onners et al., Evaluation of ipilimumab in combination with allogeneic pancreatic tumor cells transfected with a GM-CSF gene in previously treated pancreatic cancer, J. Immunother, vol.36, pp.382-389, 2013.

V. S. Lebleu, G. Taduri, J. O'connell, Y. Teng, V. G. Cooke et al., Origin and Function of Myofibroblasts in Kidney Fibrosis, Nat Med, vol.19, pp.1047-1053, 2013.

J. Leca, S. Martinez, S. Lac, J. Nigri, V. Secq et al., Cancer-associated fibroblast-derived annexin A6+ extracellular vesicles support pancreatic cancer aggressiveness, J. Clin. Invest, 2016.
URL : https://hal.archives-ouvertes.fr/hal-01408056

J. J. Lee, R. M. Perera, H. Wang, D. Wu, X. S. Liu et al., Stromal response to Hedgehog signaling restrains pancreatic cancer progression, Proc. Natl. Acad. Sci. U.S.A, vol.111, pp.3091-3100, 2014.

K. E. Lee, M. Spata, L. J. Bayne, E. L. Buza, A. C. Durham et al., Hif1a Deletion Reveals Pro-Neoplastic Function of B Cells in Pancreatic Neoplasia, Cancer Discov, vol.6, pp.256-269, 2016.

K. J. Lenos, D. M. Miedema, S. C. Lodestijn, L. E. Nijman, . Van-den et al., Stem cell functionality is microenvironmentally defined during tumour expansion and therapy response in colon cancer, Nat. Cell Biol, 2018.

K. R. Levental, H. Yu, L. Kass, J. N. Lakins, M. Egeblad et al., Matrix crosslinking forces tumor progression by enhancing integrin signaling, Cell, vol.139, pp.891-906, 2009.

X. Li, L. Nadauld, A. Ootani, D. C. Corney, R. K. Pai et al., Oncogenic transformation of diverse gastrointestinal tissues in primary organoid culture, Nat Med, vol.20, pp.769-777, 2014.

X. Li, P. Gao, Y. Wang, W. , and X. , Blood-Derived microRNAs for Pancreatic Cancer Diagnosis: A Narrative Review and Meta-Analysis, Front Physiol, vol.9, p.685, 2018.

Y. Li, T. G. Vandenboom, Z. Wang, D. Kong, S. Ali et al., , 2010.

, Up-regulation of miR-146a contributes to the inhibition of invasion of pancreatic cancer cells, Cancer Res, vol.70, p.5703

Y. Li, Z. Wei, Y. Meng, J. , and X. , ?-catenin up-regulates the expression of cyclinD1, c-myc and MMP-7 in human pancreatic cancer: Relationships with carcinogenesis and metastasis, World J Gastroenterol, vol.11, pp.2117-2123, 2005.

C. Liang, S. Shi, Q. Meng, D. Liang, S. Ji et al., Do anti-stroma therapies improve extrinsic resistance to increase the efficacy of gemcitabine in pancreatic cancer?, Cell. Mol. Life Sci, vol.75, pp.1001-1012, 2018.

E. G. Lichtenauer-kaligis, V. A. Dalm, S. P. Oomen, D. M. Mooij, P. M. Van-hagen et al., Differential expression of somatostatin receptor subtypes in human peripheral blood mononuclear cell subsets, Eur. J. Endocrinol, vol.150, pp.565-577, 2004.

E. Y. Lin, A. V. Nguyen, R. G. Russell, and J. W. Pollard, Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy, J. Exp. Med, vol.193, pp.727-740, 2001.

N. Linde, M. Casanova-acebes, M. S. Sosa, A. Mortha, A. Rahman et al., Macrophages orchestrate breast cancer early dissemination and metastasis, Nat Commun, vol.9, p.21, 2018.

G. Liou, H. Döppler, B. Necela, M. Krishna, H. C. Crawford et al., Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-?B and MMPs, J. Cell Biol, vol.202, pp.563-577, 2013.

Y. Liu and X. Cao, Characteristics and Significance of the Pre-metastatic Niche, Cancer Cell, vol.30, pp.668-681, 2016.

R. Liu, X. Chen, Y. Du, W. Yao, L. Shen et al., Serum MicroRNA Expression Profile as a Biomarker in the Diagnosis and Prognosis of Pancreatic Cancer, Clinical Chemistry, vol.58, pp.610-618, 2012.

X. Liu, H. Wu, M. Byrne, J. Jeffrey, S. Krane et al., A targeted mutation at the known collagenase cleavage site in mouse type I collagen impairs tissue remodeling, J. Cell Biol, vol.130, pp.227-237, 1995.

X. Liu, W. Mo, J. Ye, L. Li, Y. Zhang et al., , 2018.

, Regulatory T cells trigger effector T cell DNA damage and senescence caused by metabolic competition, Nat Commun, vol.9, p.249

Y. Liu, F. Li, F. Gao, L. Xing, P. Qin et al., Periostin promotes tumor angiogenesis in pancreatic cancer via Erk/VEGF signaling, Oncotarget, 2016.

Y. Liu, F. Li, F. Gao, L. Xing, P. Qin et al., Role of microenvironmental periostin in pancreatic cancer progression, Oncotarget, vol.8, pp.89552-89565, 2017.

D. Long, J. Lu, L. Luo, Y. Guo, C. Li et al., Effects of octreotide on activated pancreatic stellate cell-induced pancreas graft fibrosis in rats, J. Surg. Res, vol.176, pp.248-259, 2012.

C. López-otín and L. M. Matrisian, Emerging roles of proteases in tumour suppression, Nat. Rev. Cancer, vol.7, pp.800-808, 2007.

F. Lotti, A. M. Jarrar, R. K. Pai, M. Hitomi, J. Lathia et al., Chemotherapy activates cancer-associated fibroblasts to maintain colorectal cancer-initiating cells by IL-17A, J. Exp. Med, vol.210, pp.2851-2872, 2013.

S. Lunardi, R. J. Muschel, and T. B. Brunner, The stromal compartments in pancreatic cancer: are there any therapeutic targets?, Cancer Lett, vol.343, pp.147-155, 2014.

L. Ma, J. Teruya-feldstein, and R. A. Weinberg, Tumour invasion and metastasis initiated by microRNA-10b in breast cancer, Nature, vol.449, pp.682-688, 2007.

R. Maddipati and B. Z. Stanger, Pancreatic Cancer Metastases Harbor Evidence of Polyclonality, Cancer Discov, vol.5, pp.1086-1097, 2015.

F. Maire, S. Micard, P. Hammel, H. Voitot, P. Lévy et al., Differential diagnosis between chronic pancreatitis and pancreatic cancer: value of the detection of KRAS2 mutations in circulating DNA, Br J Cancer, vol.87, pp.551-554, 2002.

A. Maitra, N. Fukushima, K. Takaori, and R. H. Hruban, Precursors to invasive pancreatic cancer, Adv Anat Pathol, vol.12, pp.81-91, 2005.

T. Maj, W. Wang, J. Crespo, H. Zhang, W. Wang et al., Oxidative stress controls regulatory T cell apoptosis and suppressor activity and PD-L1-blockade resistance in tumor, Nat. Immunol, vol.18, pp.1332-1341, 2017.

I. W. Mak, N. Evaniew, and M. Ghert, Lost in translation: animal models and clinical trials in cancer treatment, Am J Transl Res, vol.6, pp.114-118, 2014.

A. P. Makohon-moore, M. Zhang, J. G. Reiter, I. Bozic, B. Allen et al., Limited heterogeneity of known driver gene mutations among the metastases of individual patients with pancreatic cancer, Nature Genetics, vol.49, pp.358-366, 2017.

A. P. Makohon-moore, K. Matsukuma, M. Zhang, J. G. Reiter, J. M. Gerold et al., Precancerous neoplastic cells can move through the pancreatic ductal system, Nature, vol.1, 2018.

A. Maliar, C. Servais, T. Waks, M. Chmielewski, R. Lavy et al., Redirected T cells that target pancreatic adenocarcinoma antigens eliminate tumors and metastases in mice, Gastroenterology, vol.143, pp.1375-1384, 2012.

A. Mantovani, F. Marchesi, A. Malesci, L. Laghi, A. et al., Tumourassociated macrophages as treatment targets in oncology, Nat Rev Clin Oncol advance online publication, 2017.

F. O. Martinez, G. , and S. , The M1 and M2 paradigm of macrophage activation: time for reassessment, 1000.

A. Masamune, S. Hamada, K. Kikuta, T. Takikawa, S. Miura et al., The angiotensin II type I receptor blocker olmesartan inhibits the growth of pancreatic cancer by targeting stellate cell activities in mice, Scand. J. Gastroenterol, vol.48, pp.602-609, 2013.

S. A. Melo, L. B. Luecke, C. Kahlert, A. F. Fernandez, S. T. Gammon et al., Glypican-1 identifies cancer exosomes and detects early pancreatic cancer, Nature, vol.523, pp.177-182, 2015.

R. Mentlein, O. Eichler, F. Forstreuter, and J. Held-feindt, Somatostatin inhibits the production of vascular endothelial growth factor in human glioma cells, Int. J. Cancer, vol.92, pp.545-550, 2001.

P. Michl and T. M. Gress, Current concepts and novel targets in advanced pancreatic cancer, Gut, vol.62, pp.317-326, 2013.

A. Mielgo and M. C. Schmid, Impact of tumour associated macrophages in pancreatic cancer, BMB Rep, vol.46, pp.131-138, 2013.

F. L. Miles, F. L. Pruitt, K. L. Van-golen, and C. R. Cooper, Stepping out of the flow: capillary extravasation in cancer metastasis, Clin. Exp. Metastasis, vol.25, pp.305-324, 2008.

B. W. Miller, J. P. Morton, M. Pinese, G. Saturno, N. B. Jamieson et al., Targeting the LOX/hypoxia axis reverses many of the features that make pancreatic cancer deadly: inhibition of LOX abrogates metastasis and enhances drug efficacy, EMBO Mol Med, vol.7, pp.1063-1076, 2015.

C. R. Millrud, C. Bergenfelz, and K. Leandersson, On the origin of myeloid-derived suppressor cells, Oncotarget, vol.8, pp.3649-3665, 2017.

J. B. Mitchem, D. J. Brennan, B. L. Knolhoff, B. A. Belt, Y. Zhu et al., Targeting tumor-infiltrating macrophages decreases tumor-initiating cells, relieves immunosuppression and improves chemotherapeutic responses, Cancer Res, vol.73, pp.1128-1141, 2013.

A. K. Mitra, M. Zillhardt, Y. Hua, P. Tiwari, A. E. Murmann et al., MicroRNAs reprogram normal fibroblasts into cancer-associated fibroblasts in ovarian cancer, Cancer Discov, vol.2, pp.1100-1108, 2012.

S. Moatassim-billah, C. Duluc, R. Samain, C. Jean, A. Perraud et al., Anti-metastatic potential of somatostatin analog SOM230: Indirect pharmacological targeting of pancreatic cancerassociated fibroblasts, Oncotarget, vol.7, pp.41584-41598, 2016.
URL : https://hal.archives-ouvertes.fr/hal-02421440

R. A. Moffitt, R. Marayati, E. L. Flate, K. E. Volmar, S. G. Loeza et al., Virtual microdissection identifies distinct tumor-and stroma-specific subtypes of pancreatic ductal adenocarcinoma, Nat Genet, vol.47, pp.1168-1178, 2015.

L. Moreira, B. Bakir, P. Chatterji, Z. Dantes, M. Reichert et al., , 2018.

. Pancreas and . Organoids, Current and Future Aspects as a Research Platform for Personalized Medicine in Pancreatic Cancer, Cell Mol Gastroenterol Hepatol, vol.5, pp.289-298

C. A. Moskaluk, R. H. Hruban, and S. E. Kern, p16 and K-ras gene mutations in the intraductal precursors of human pancreatic adenocarcinoma, Cancer Res, vol.57, pp.2140-2143, 1997.

K. Movahedi, M. Guilliams, J. Van-den-bossche, R. Van-den-bergh, C. Gysemans et al., Identification of discrete tumor-induced myeloid-derived suppressor cell subpopulations with distinct T cellsuppressive activity, Blood, vol.111, pp.4233-4244, 2008.

S. Mueller, T. Engleitner, R. Maresch, M. Zukowska, S. Lange et al., Evolutionary routes and KRAS dosage define pancreatic cancer phenotypes, Nature, vol.554, pp.62-68, 2018.

A. Naba, K. R. Clauser, S. Hoersch, H. Liu, S. A. Carr et al., The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices, Mol Cell Proteomics, vol.11, 2012.

Y. Nakai, H. Isayama, H. Ijichi, T. Sasaki, N. Sasahira et al., Inhibition of renin-angiotensin system affects prognosis of advanced pancreatic cancer receiving gemcitabine, Br. J. Cancer, vol.103, pp.1644-1648, 2010.

S. Nakamori, M. Kameyama, S. Imaoka, H. Furukawa, O. Ishikawa et al., Increased expression of sialyl Lewisx antigen correlates with poor survival in patients with colorectal carcinoma: clinicopathological and immunohistochemical study, Cancer Res, vol.53, pp.3632-3637, 1993.

Y. Nakazawa, Y. Taniyama, F. Sanada, R. Morishita, S. Nakamori et al., Periostin blockade overcomes chemoresistance via restricting the expansion of mesenchymal tumor subpopulations in breast cancer, Scientific Reports, vol.8, p.4013, 2018.

A. Neesse, K. K. Frese, T. E. Bapiro, T. Nakagawa, M. D. Sternlicht et al., CTGF antagonism with mAb FG-3019 enhances chemotherapy response without increasing drug delivery in murine ductal pancreas cancer, Proc. Natl. Acad. Sci. U.S.A, vol.110, pp.12325-12330, 2013.

A. Neesse, H. Algül, D. A. Tuveson, and T. M. Gress, Stromal biology and therapy in pancreatic cancer: a changing paradigm, Gut, vol.64, pp.1476-1484, 2015.

J. P. Neoptolemos, J. Kleeff, P. Michl, E. Costello, W. Greenhalf et al., Therapeutic developments in pancreatic cancer: current and future perspectives, Nat Rev Gastroenterol Hepatol, vol.15, pp.333-348, 2018.

C. Neuzillet, J. Bachet, L. Bauguion, L. Colson-durand, and P. Hammel, Cancer du pancréas». Thésaurus National de Cancérologie Digestive, 2018.

X. Ni, J. Tao, J. Barbi, Q. Chen, B. V. Park et al., YAP Is Essential for Treg-Mediated Suppression of Antitumor Immunity, Cancer Discov, vol.8, pp.1026-1043, 2018.

R. Nicolle, Y. Blum, L. Marisa, C. Loncle, O. Gayet et al., Pancreatic Adenocarcinoma Therapeutic Targets Revealed by Tumor-Stroma Cross-Talk Analyses in Patient-Derived Xenografts, Cell Reports, vol.21, pp.2458-2470, 2017.
URL : https://hal.archives-ouvertes.fr/inserm-01985259

M. S. Nicoloso, R. Spizzo, M. Shimizu, S. Rossi, and G. A. Calin, MicroRNAsthe micro steering wheel of tumour metastases, Nature Reviews Cancer, vol.9, pp.293-302, 2009.

S. R. Nielsen, V. Quaranta, A. Linford, P. Emeagi, C. Rainer et al., Macrophage-secreted granulin supports pancreatic cancer metastasis by inducing liver fibrosis, Nat. Cell Biol, vol.18, pp.549-560, 2016.

U. Nitsche, B. Kong, A. Balmert, H. Friess, and J. Kleeff, Should every patient with pancreatic cancer receive perioperative/neoadjuvant therapy?, Indian J Med Paediatr Oncol, vol.37, pp.211-213, 2016.

G. Niu, K. L. Wright, M. Huang, L. Song, E. Haura et al., Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis, Oncogene, vol.21, 2000.

E. M. Noll, C. Eisen, A. Stenzinger, E. Espinet, A. Muckenhuber et al., CYP3A5 mediates basal and acquired therapy resistance in different subtypes of pancreatic ductal adenocarcinoma, Nature Medicine, vol.22, pp.278-287, 2016.

A. Nomura, V. K. Gupta, P. Dauer, N. S. Sharma, V. Dudeja et al., NF?B-Mediated Invasiveness in CD133 + Pancreatic TICs Is Regulated by Autocrine and Paracrine Activation of IL1 Signaling, Molecular Cancer Research, vol.16, pp.162-172, 2018.

T. M. Nywening, A. Wang-gillam, D. E. Sanford, B. A. Belt, R. Z. Panni et al., Targeting tumourassociated macrophages with CCR2 inhibition in combination with FOLFIRINOX in patients with borderline resectable and locally advanced pancreatic cancer: a single-centre, open-label, dose-finding, non-randomised, phase 1b trial, The Lancet Oncology, vol.17, pp.651-662, 2016.

T. M. Nywening, B. A. Belt, D. R. Cullinan, R. Z. Panni, B. J. Han et al., Targeting both tumour-associated CXCR2+ neutrophils and CCR2+ macrophages disrupts myeloid recruitment and improves chemotherapeutic responses in pancreatic ductal adenocarcinoma, Gut, vol.67, pp.1112-1123, 2018.

H. Oh, Y. Grinberg-bleyer, W. Liao, D. Maloney, P. Wang et al., An NF-?B Transcription-Factor-Dependent Lineage-Specific Transcriptional Program Promotes Regulatory T Cell Identity and Function, Immunity, vol.47, pp.450-465, 2017.

D. Ohlund, C. Lundin, B. Ardnor, M. Oman, P. Naredi et al., Type IV collagen is a tumour stroma-derived biomarker for pancreas cancer, Br. J. Cancer, vol.101, pp.91-97, 2009.

D. Öhlund, O. Franklin, E. Lundberg, C. Lundin, and M. Sund, Type IV collagen stimulates pancreatic cancer cell proliferation, migration, and inhibits apoptosis through an autocrine loop, BMC Cancer, vol.13, p.154, 2013.

D. Öhlund, E. Elyada, and D. Tuveson, Fibroblast heterogeneity in the cancer wound, J Exp Med, vol.211, pp.1503-1523, 2014.

D. Öhlund, A. Handly-santana, G. Biffi, E. Elyada, A. S. Almeida et al., Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer, J. Exp. Med, 2017.

O. Olivares, J. R. Mayers, V. Gouirand, M. E. Torrence, T. Gicquel et al., Collagen-derived proline promotes pancreatic ductal adenocarcinoma cell survival under nutrient limited conditions, Nat Commun, vol.8, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01788014

K. P. Olive, M. A. Jacobetz, C. J. Davidson, A. Gopinathan, D. Mcintyre et al., Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer, Science, vol.324, p.1457, 2009.

O. C. Olson, H. Kim, D. F. Quail, E. A. Foley, J. et al., Tumor-Associated Macrophages Suppress the Cytotoxic Activity of Antimitotic Agents, Cell Rep, vol.19, pp.101-113, 2017.

M. B. Omary, A. Lugea, A. W. Lowe, and S. J. Pandol, The pancreatic stellate cell: a star on the rise in pancreatic diseases, J Clin Invest, vol.117, pp.50-59, 2007.

A. Orimo, P. B. Gupta, D. C. Sgroi, F. Arenzana-seisdedos, T. Delaunay et al., Stromal fibroblasts present in invasive human breast carcinomas promote tumor growth and angiogenesis through elevated SDF-1/CXCL12 secretion, Cell, vol.121, pp.335-348, 2005.

H. Ouyang, J. Gore, S. Deitz, and M. Korc, microRNA-10b enhances pancreatic cancer cell invasion by suppressing TIP30 expression and promoting EGF and TGF-? actions, Oncogene, vol.33, pp.4664-4674, 2014.

M. Ouzounova, E. Lee, R. Piranlioglu, A. E. Andaloussi, R. Kolhe et al., Monocytic and granulocytic myeloid derived suppressor cells differentially regulate spatiotemporal tumour plasticity during metastatic cascade, Nature Communications, vol.8, p.14979, 2017.

A. E. Overacre-delgoffe, M. Chikina, R. E. Dadey, H. Yano, E. A. Brunazzi et al., Interferon-? Drives Treg Fragility to Promote Anti-tumor Immunity, Cell, vol.169, pp.1130-1141, 2017.

B. C. Özdemir, T. Pentcheva-hoang, J. L. Carstens, X. Zheng, C. Wu et al., Depletion of carcinomaassociated fibroblasts and fibrosis induces immunosuppression and accelerates pancreas cancer with reduced survival, Cancer Cell, vol.25, pp.719-734, 2014.

G. Pascual, A. Avgustinova, S. Mejetta, M. Martín, A. Castellanos et al., Targeting metastasis-initiating cells through the fatty acid receptor CD36, Nature, vol.541, pp.41-45, 2017.

Y. C. Patel, Somatostatin and Its Receptor Family, Frontiers in Neuroendocrinology, vol.20, pp.157-198, 1999.

M. Pein and T. Oskarsson, Microenvironment in metastasis: roadblocks and supportive niches, American Journal of Physiology-Cell Physiology, vol.309, pp.627-638, 2015.

H. Peinado, H. Zhang, I. R. Matei, B. Costa-silva, A. Hoshino et al., Pre-metastatic niches: organ-specific homes for metastases, Nature Reviews Cancer, vol.17, pp.302-317, 2017.

R. D. Peixoto, M. Ho, D. J. Renouf, H. J. Lim, S. Gill et al., Eligibility of Metastatic Pancreatic Cancer Patients for First-Line Palliative Intent nab-Paclitaxel Plus Gemcitabine Versus FOLFIRINOX, Am. J. Clin. Oncol, vol.40, pp.507-511, 2017.

M. Pergamo and G. Miller, Myeloid-derived suppressor cells and their role in pancreatic cancer, Cancer Gene Ther, vol.24, pp.100-105, 2017.

P. A. Philip, J. Benedetti, C. L. Corless, R. Wong, E. M. O'reilly et al., Phase III study comparing gemcitabine plus cetuximab versus gemcitabine in patients with advanced pancreatic adenocarcinoma: Southwest Oncology Group-directed intergroup trial S0205, J. Clin. Oncol, vol.28, pp.3605-3610, 2010.

M. W. Pickup, J. K. Mouw, and V. M. Weaver, The extracellular matrix modulates the hallmarks of cancer, EMBO Rep, vol.15, pp.1243-1253, 2014.

K. E. Poruk, M. A. Firpo, D. G. Adler, and S. J. Mulvihill, Screening for pancreatic cancer: why, how, and who?, Ann. Surg, vol.257, pp.17-26, 2013.

A. D. Posey, R. D. Schwab, A. C. Boesteanu, C. Steentoft, U. Mandel et al., Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma, Immunity, vol.44, pp.1444-1454, 2016.

S. P. Pothula, Z. Xu, D. Goldstein, A. V. Biankin, R. C. Pirola et al.,

, Hepatocyte growth factor inhibition: a novel therapeutic approach in pancreatic cancer, Br. J. Cancer, vol.114, pp.269-280

S. P. Pothula, Z. Xu, D. Goldstein, N. Merrett, R. C. Pirola et al., Targeting the HGF/c-MET pathway: stromal remodelling in pancreatic cancer, Oncotarget, vol.8, pp.76722-76739, 2017.

S. J. Priceman, J. L. Sung, Z. Shaposhnik, J. B. Burton, A. X. Torres-collado et al., Targeting distinct tumor-infiltrating myeloid cells by inhibiting CSF-1 receptor: combating tumor evasion of antiangiogenic therapy, Blood, vol.115, pp.1461-1471, 2010.

P. P. Provenzano, C. Cuevas, A. E. Chang, V. K. Goel, V. Hoff et al., Enzymatic targeting of the stroma ablates physical barriers to treatment of pancreatic ductal adenocarcinoma, Cancer Cell, vol.21, pp.418-429, 2012.

B. Psaila and D. Lyden, The metastatic niche: adapting the foreign soil, Nat. Rev. Cancer, vol.9, pp.285-293, 2009.

S. M. Pyonteck, L. Akkari, A. J. Schuhmacher, R. L. Bowman, L. Sevenich et al., CSF-1R inhibition alters macrophage polarization and blocks glioma progression, Nat. Med, vol.19, pp.1264-1272, 2013.

S. Pyronnet, C. Bousquet, S. Najib, R. Azar, H. Laklai et al., Antitumor effects of somatostatin, Mol. Cell. Endocrinol, vol.286, pp.230-237, 2008.
URL : https://hal.archives-ouvertes.fr/hal-00531996

B. Qian, J. Li, H. Zhang, T. Kitamura, J. Zhang et al., CCL2 recruits inflammatory monocytes to facilitate breasttumour metastasis, Nature, vol.475, pp.222-225, 2011.

D. F. Quail, R. L. Bowman, L. Akkari, M. L. Quick, A. J. Schuhmacher et al., The tumor microenvironment underlies acquired resistance to CSF-1R inhibition in gliomas, Science, vol.352, p.3018, 2016.

V. Quaranta, C. Rainer, S. R. Nielsen, M. L. Raymant, M. S. Ahmed et al., Macrophage-Derived Granulin Drives Resistance to Immune Checkpoint Inhibition in Metastatic Pancreatic Cancer, Cancer Res, vol.78, pp.4253-4269, 2018.

U. Rai, T. R. Thrimawithana, C. Valery, Y. , and S. A. , Therapeutic uses of somatostatin and its analogues: Current view and potential applications, Pharmacol. Ther, vol.152, pp.98-110, 2015.

D. Raj, M. Yang, D. Rodgers, E. N. Hampton, J. Begum et al., Switchable CAR-T cells mediate remission in metastatic pancreatic ductal adenocarcinoma, 2018.

J. S. Rawlings, K. M. Rosler, and D. A. Harrison, The JAK/STAT signaling pathway, Journal of Cell Science, vol.117, pp.1281-1283, 2004.

C. Rébé, F. Végran, H. Berger, and F. Ghiringhelli, STAT3 activation: A key factor in tumor immunoescape, p.23010, 2013.

M. Reichert, B. Bakir, L. Moreira, J. R. Pitarresi, K. Feldmann et al., Regulation of Epithelial Plasticity Determines Metastatic Organotropism in Pancreatic Cancer, Dev. Cell, vol.45, pp.696-711, 2018.

J. G. Reiter, A. P. Makohon-moore, J. M. Gerold, A. Heyde, M. A. Attiyeh et al., Minimal functional driver gene heterogeneity among untreated metastases, Science, vol.361, pp.1033-1037, 2018.

N. Reymond, B. B. Água, and A. J. Ridley, Crossing the endothelial barrier during metastasis, Nature Reviews Cancer, vol.13, pp.858-870, 2013.

H. Reynaert, F. Vaeyens, H. Qin, K. Hellemans, N. Chatterjee et al., Somatostatin suppresses endothelin-1-induced rat hepatic stellate cell contraction via somatostatin receptor subtype 1, Gastroenterology, vol.121, pp.915-930, 2001.

H. Reynaert, K. Rombouts, Y. Jia, D. Urbain, N. Chatterjee et al., Somatostatin at nanomolar concentration reduces collagen I and III synthesis by, but not proliferation of activated rat hepatic stellate cells, Br. J. Pharmacol, vol.146, pp.77-88, 2005.

A. D. Rhim, E. T. Mirek, N. M. Aiello, A. Maitra, J. M. Bailey et al., EMT and dissemination precede pancreatic tumor formation, Cell, vol.148, pp.349-361, 2012.

A. D. Rhim, P. E. Oberstein, D. H. Thomas, E. T. Mirek, C. F. Palermo et al., Stromal elements act to restrain, rather than support, pancreatic ductal adenocarcinoma, Cancer Cell, vol.25, pp.735-747, 2014.

C. H. Ries, M. A. Cannarile, S. Hoves, J. Benz, K. Wartha et al., Targeting tumor-associated macrophages with anti-CSF-1R antibody reveals a strategy for cancer therapy, Cancer Cell, vol.25, pp.846-859, 2014.

N. J. Roberts, A. L. Norris, G. M. Petersen, M. L. Bondy, R. Brand et al., Whole Genome Sequencing Defines the Genetic Heterogeneity of Familial Pancreatic Cancer, Cancer Discov, vol.6, pp.166-175, 2016.

P. C. Rodriguez, D. G. Quiceno, J. Zabaleta, B. Ortiz, A. H. Zea et al., Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigenspecific T-cell responses, Cancer Res, vol.64, pp.5839-5849, 2004.

T. L. Rogers and I. Holen, Tumour macrophages as potential targets of bisphosphonates, J Transl Med, vol.9, p.177, 2011.

D. Roife, B. Dai, Y. Kang, M. V. Perez, M. Pratt et al., Ex Vivo Testing of Patient-Derived Xenografts Mirrors the Clinical Outcome of Patients with Pancreatic Ductal Adenocarcinoma, Clin. Cancer Res, vol.22, pp.6021-6030, 2016.

T. D. Ross, B. G. Coon, S. Yun, N. Baeyens, K. Tanaka et al., Integrins In Mechanotransduction. Curr Opin Cell Biol, vol.25, pp.613-618, 2013.

A. R. Rowson-hodel, J. H. Wald, J. Hatakeyama, W. K. O'neal, J. R. Stonebraker et al., , 2018.

, Membrane Mucin Muc4 promotes blood cell association with tumor cells and mediates efficient metastasis in a mouse model of breast cancer, Oncogene, vol.37, pp.197-207

M. Saio, S. Radoja, M. Marino, and A. B. Frey, Tumor-infiltrating macrophages induce apoptosis in activated CD8(+) T cells by a mechanism requiring cell contact and mediated by both the cell-associated form of TNF and nitric oxide, J. Immunol, vol.167, pp.5583-5593, 2001.

M. S. Samuel, J. I. Lopez, E. J. Mcghee, D. R. Croft, D. Strachan et al., Actomyosin-mediated cellular tension drives increased tissue stiffness and ?-catenin activation to induce interfollicular epidermal hyperplasia and tumor growth, Cancer Cell, vol.19, pp.776-791, 2011.

J. Z. Sanborn, J. Chung, E. Purdom, N. J. Wang, H. Kakavand et al., Phylogenetic analyses of melanoma reveal complex patterns of metastatic dissemination, Proceedings of the National Academy of Sciences, vol.112, pp.10995-11000, 2015.

E. Sato, S. H. Olson, J. Ahn, B. Bundy, H. Nishikawa et al., Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer, Proc. Natl. Acad. Sci. U.S.A, vol.102, pp.18538-18543, 2005.

T. Sato, R. G. Vries, H. J. Snippert, M. Wetering, . Van-de et al., Single Lgr5 stem cells build crypt–villus structures in vitro without a mesenchymal niche, Nature, vol.459, pp.262-265, 2009.

T. Sato, D. E. Stange, M. Ferrante, R. G. Vries, J. H. Van-es et al., Long-term expansion of epithelial organoids from human colon, adenoma, adenocarcinoma, and Barrett's epithelium, Gastroenterology, vol.141, pp.1762-1772, 2011.

M. Sausen, J. Phallen, V. Adleff, S. Jones, R. J. Leary et al., Clinical implications of genomic alterations in the tumour and circulation of pancreatic cancer patients, Nat Commun, vol.6, p.7686, 2015.

A. V. Schally, W. Y. Huang, R. C. Chang, A. Arimura, T. W. Redding et al., Isolation and structure of pro-somatostatin: a putative somatostatin precursor from pig hypothalamus, Proc. Natl. Acad. Sci. U.S.A, vol.77, pp.4489-4493, 1980.

R. Scharfmann, X. Xiao, H. Heimberg, J. Mallet, and P. Ravassard, Beta cells within single human islets originate from multiple progenitors, PLoS ONE, vol.3, p.3559, 2008.

W. Schneiderhan, F. Diaz, M. Fundel, S. Zhou, M. Siech et al., Pancreatic stellate cells are an important source of MMP-2 in human pancreatic cancer and accelerate tumor progression in a murine xenograft model and CAM assay, J. Cell. Sci, vol.120, pp.512-519, 2007.

N. Schönhuber, B. Seidler, K. Schuck, C. Veltkamp, C. Schachtler et al., A next-generation dual-recombinase system for time and host specific targeting of pancreatic cancer, Nat Med, vol.20, pp.1340-1347, 2014.

R. D. Schreiber, L. J. Old, and M. J. Smyth, Cancer immunoediting: integrating immunity's roles in cancer suppression and promotion, Science, vol.331, pp.1565-1570, 2011.

B. Schultheis, D. Reuter, M. P. Ebert, J. Siveke, A. Kerkhoff et al., Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb study, Ann Oncol, vol.28, pp.2429-2435, 2017.

K. Sharma, Y. C. Patel, and C. B. Srikant, Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3, Mol. Endocrinol, vol.10, pp.1688-1696, 1996.

M. E. Shaul and Z. G. Fridlender, Cancer related circulating and tumor-associated neutrophils -subtypes, sources and function, The FEBS Journal, vol.0

A. V. Sheahan, A. V. Biankin, C. R. Parish, and L. M. Khachigian, Targeted therapies in the management of locally advanced and metastatic pancreatic cancer: a systematic review, Oncotarget, vol.9, pp.21613-21627, 2018.

M. H. Sherman, R. T. Yu, D. D. Engle, N. Ding, A. R. Atkins et al., Vitamin D receptor-mediated stromal reprogramming suppresses pancreatitis and enhances pancreatic cancer therapy, Cell, vol.159, pp.80-93, 2014.

Q. Shi and D. Boettiger, A novel mode for integrin-mediated signaling: tethering is required for phosphorylation of FAK Y397, Mol. Biol. Cell, vol.14, pp.4306-4315, 2003.

Y. Shintani, M. A. Hollingsworth, M. J. Wheelock, J. , and K. R. , Collagen I promotes metastasis in pancreatic cancer by activating c-Jun NH(2)-terminal kinase 1 and upregulating N-cadherin expression, Cancer Res, vol.66, pp.11745-11753, 2006.

Y. Shiozawa, J. E. Berry, M. R. Eber, Y. Jung, K. Yumoto et al., The marrow niche controls the cancer stem cell phenotype of disseminated prostate cancer, Oncotarget, vol.7, pp.41217-41232, 2016.

K. Sideras, H. Braat, J. Kwekkeboom, C. H. Van-eijck, M. P. Peppelenbosch et al., Role of the immune system in pancreatic cancer progression and immune modulating treatment strategies, Cancer Treat. Rev, vol.40, pp.513-522, 2014.

B. N. Singh, J. Fu, R. K. Srivastava, and S. Shankar, Hedgehog Signaling Antagonist GDC-0449 (Vismodegib) Inhibits Pancreatic Cancer Stem Cell Characteristics: Molecular Mechanisms, PLOS ONE, vol.6, 2011.

M. S. Sosa, P. Bragado, and J. A. Aguirre-ghiso, Mechanisms of disseminated cancer cell dormancy: an awakening field, Nat Rev Cancer, vol.14, pp.611-622, 2014.

C. E. Steding, S. Wu, Y. Zhang, M. Jeng, B. D. Elzey et al., The role of interleukin-12 on modulating myeloid-derived suppressor cells, increasing overall survival and reducing metastasis, Immunology, vol.133, pp.221-238, 2011.

C. W. Steele, S. A. Karim, J. D. Leach, P. Bailey, R. Upstill-goddard et al., CXCR2 Inhibition Profoundly Suppresses Metastases and Augments Immunotherapy in Pancreatic Ductal Adenocarcinoma, 2016.

N. H. Stoecklein, S. B. Hosch, M. Bezler, F. Stern, C. H. Hartmann et al., Direct genetic analysis of single disseminated cancer cells for prediction of outcome and therapy selection in esophageal cancer, Cancer Cell, vol.13, pp.441-453, 2008.

J. B. Stokes, S. J. Adair, J. K. Slack-davis, D. M. Walters, R. W. Tilghman et al., Inhibition of focal adhesion kinase by PF-562,271 inhibits the growth and metastasis of pancreatic cancer concomitant with altering the tumor microenvironment, Mol. Cancer Ther, vol.10, pp.2135-2145, 2011.

K. Stoletov, L. Willetts, R. J. Paproski, D. J. Bond, S. Raha et al., Quantitative in vivo whole genome motility screen reveals novel therapeutic targets to block cancer metastasis, Nat Commun, vol.9, p.2343, 2018.

D. C. Strachan, B. Ruffell, Y. Oei, M. J. Bissell, L. M. Coussens et al., CSF1R inhibition delays cervical and mammary tumor growth in murine models by attenuating the turnover of tumor-associated macrophages and enhancing infiltration by CD8+ T cells, vol.2, p.26968, 2013.

I. M. Stromnes, J. S. Brockenbrough, K. Izeradjene, M. A. Carlson, C. Cuevas et al., Targeted depletion of an MDSC subset unmasks pancreatic ductal adenocarcinoma to adaptive immunity, Gut, vol.63, pp.1769-1781, 2014.

I. M. Stromnes, T. M. Schmitt, A. Hulbert, J. S. Brockenbrough, H. N. Nguyen et al., T Cells Engineered against a Native Antigen Can Surmount Immunologic and Physical Barriers to Treat Pancreatic Ductal Adenocarcinoma, Cancer Cell, vol.28, pp.638-652, 2015.

S. Su, J. Chen, H. Yao, J. Liu, S. Yu et al., CD10+GPR77+ Cancer-Associated Fibroblasts Promote Cancer Formation and Chemoresistance by Sustaining Cancer Stemness, Cell, vol.172, pp.841-856, 2018.

R. Subramani, L. Gangwani, S. B. Nandy, A. Arumugam, M. Chattopadhyay et al., Emerging roles of microRNAs in pancreatic cancer diagnosis, therapy and prognosis (Review), Int J Oncol, vol.47, pp.1203-1210, 2015.

Y. Suleiman, A. Mahipal, D. Shibata, E. M. Siegel, H. Jump et al., Phase I study of combination of pasireotide LAR + gemcitabine in locally advanced or metastatic pancreatic cancer, Cancer Chemother. Pharmacol, vol.76, pp.481-487, 2015.

C. Susini and L. Buscail, Rationale for the use of somatostatin analogs as antitumor agents, Ann. Oncol, vol.17, pp.1733-1742, 2006.

K. Suzuki, S. Takano, H. Yoshitomi, H. Nishino, S. Kagawa et al., Metadherin promotes metastasis by supporting putative cancer stem cell properties and epithelial plasticity in pancreatic cancer, Oncotarget, vol.8, pp.66098-66111, 2017.

C. Tai, M. Huang, C. Wu, C. Wang, C. Tai et al., Combination of Two Targeted Medications (Bevacizumab Plus Cetuximab) Improve the Therapeutic Response of Pancreatic Carcinoma, p.3259, 2016.

H. Takahashi, K. Sakakura, T. Kudo, M. Toyoda, K. Kaira et al., Cancer-associated fibroblasts promote an immunosuppressive microenvironment through the induction and accumulation of protumoral macrophages, Oncotarget, 2016.

M. Taki, K. Abiko, T. Baba, J. Hamanishi, K. Yamaguchi et al., Snail promotes ovarian cancer progression by recruiting myeloid-derived suppressor cells via CXCR2 ligand upregulation, Nat Commun, vol.9, p.1685, 2018.

C. J. Tape, S. Ling, M. Dimitriadi, K. M. Mcmahon, J. D. Worboys et al., Oncogenic KRAS Regulates Tumor Cell Signaling via Stromal Reciprocation. Cell, 2016.

Y. Teng, J. L. Ross, and J. K. Cowell, The involvement of JAK-STAT3 in cell motility, invasion, and metastasis, vol.3, 2014.

M. Theodoropoulou and G. K. Stalla, Somatostatin receptors: from signaling to clinical practice, Front Neuroendocrinol, vol.34, pp.228-252, 2013.

D. A. Tipton and M. K. Dabbous, Autocrine Transforming Growth Factor ? Stimulation of Extracellular Matrix Production by Fibroblasts From Fibrotic Human Gingiva, Journal of Periodontology, vol.69, pp.609-619, 1998.

H. Tiriac, P. Belleau, D. D. Engle, D. Plenker, A. Deschênes et al., Organoid profiling identifies common responders to chemotherapy in pancreatic cancer, Cancer Discov, 2018.

P. A. Toste, A. H. Nguyen, B. E. Kadera, M. Duong, N. Wu et al., Chemotherapy-induced Inflammatory Gene Signature and Pro-tumorigenic Phenotype in Pancreatic CAFs via Stress-associated MAPK, Mol Cancer Res, vol.14, pp.437-447, 2016.

S. Tu, G. Bhagat, G. Cui, S. Takaishi, E. A. Kurt-jones et al., Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice, Cancer Cell, vol.14, pp.408-419, 2008.

C. R. Vakoc and D. A. Tuveson, Soils and Seeds That Initiate Pancreatic Cancer Metastasis, Cancer Discovery, vol.7, pp.1067-1068, 2017.

S. Valastyan and R. A. Weinberg, Tumor metastasis: molecular insights and evolving paradigms, Cell, vol.147, pp.275-292, 2011.

K. C. Valkenburg, A. E. De-groot, and K. J. Pienta, Targeting the tumour stroma to improve cancer therapy, Nature Reviews Clinical Oncology, vol.15, pp.366-381, 2018.

C. Vennin, V. T. Chin, S. C. Warren, M. C. Lucas, D. Herrmann et al., Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis, Sci Transl Med, vol.9, 2017.

C. Vennin, K. J. Murphy, J. P. Morton, T. R. Cox, M. Pajic et al., Reshaping the Tumor Stroma for Treatment of Pancreatic Cancer, Gastroenterology, vol.154, pp.820-838, 2018.

G. Vlachogiannis, S. Hedayat, A. Vatsiou, Y. Jamin, J. Fernández-mateos et al., Patient-derived organoids model treatment response of metastatic gastrointestinal cancers, Science, vol.359, pp.920-926, 2018.

A. Vonlaufen, S. Joshi, C. Qu, P. A. Phillips, Z. Xu et al., Pancreatic Stellate Cells: Partners in Crime with Pancreatic Cancer Cells, Cancer Res, vol.68, pp.2085-2093, 2008.

T. Voskoglou-nomikos, J. L. Pater, and L. Seymour, Clinical Predictive Value of the in Vitro Cell Line, Human Xenograft, and Mouse Allograft Preclinical Cancer Models, p.14

N. Waddell, M. Pajic, A. Patch, D. K. Chang, K. S. Kassahn et al., Whole genomes redefine the mutational landscape of pancreatic cancer, Nature, vol.518, pp.495-501, 2015.

M. Waghray, M. Yalamanchili, M. Dziubinski, M. Zeinali, M. Erkkinen et al., GM-CSF Mediates Mesenchymal-Epithelial Crosstalk in Pancreatic Cancer. Cancer Discov, 2016.

H. Wang, C. Yu, X. Gao, T. Welte, A. M. Muscarella et al., The Osteogenic Niche Promotes Early-Stage Bone Colonization of Disseminated Breast Cancer Cells, Cancer Cell, vol.27, pp.193-210, 2015.

P. Wang, L. Chen, J. Zhang, H. Chen, J. Fan et al., Methylation-mediated silencing of the miR-124 genes facilitates pancreatic cancer progression and metastasis by targeting Rac1, Oncogene, vol.33, pp.514-524, 2014.

X. Wang, S. O. Lee, S. Xia, Q. Jiang, J. Luo et al., , 2013.

, Endothelial cells enhance prostate cancer metastasis via IL-6?androgen receptor?TGF-??MMP-9 signals, Mol. Cancer Ther, vol.12, pp.1026-1037

X. Wang, G. Luo, K. Zhang, J. Cao, C. Huang et al., Hypoxic tumor-derived exosomal miR-301a mediates M2 macrophage polarization via PTEN/PI3K? to promote pancreatic cancer metastasis, Cancer Res, 2018.

Y. Wang, Z. Li, S. Zheng, Y. Zhou, L. Zhao et al., Expression profile of long non-coding RNAs in pancreatic cancer and their clinical significance as biomarkers, Oncotarget, vol.6, pp.35684-35698, 2015.

J. C. Watson, D. A. Balster, B. M. Gebhardt, T. M. O'dorisio, M. S. O'dorisio et al., Growing vascular endothelial cells express somatostatin subtype 2 receptors, Br. J. Cancer, vol.85, pp.266-272, 2001.

S. K. Wculek and I. Malanchi, Neutrophils support lung colonization of metastasisinitiating breast cancer cells, Nature, vol.528, pp.413-417, 2015.

C. K. Weber, G. Sommer, P. Michl, H. Fensterer, M. Weimer et al., Biglycan is overexpressed in pancreatic cancer and induces G1-arrest in pancreatic cancer cell lines, Gastroenterology, vol.121, pp.657-667, 2001.

A. Y. Wehr, E. E. Furth, V. Sangar, I. A. Blair, Y. et al., Analysis of the Human Pancreatic Stellate Cell Secreted Proteome, Pancreas, vol.40, pp.557-566, 2011.

G. J. Weiss, J. Waypa, L. Blaydorn, J. Coats, K. Mcgahey et al., A phase Ib study of pembrolizumab plus chemotherapy in patients with advanced cancer (PembroPlus), Br. J. Cancer, vol.117, pp.33-40, 2017.

T. Welte, I. S. Kim, L. Tian, X. Gao, H. Wang et al., Oncogenic mTOR signaling recruits myeloid-derived suppressor cells to promote tumor initiation, Nat Cell Biol, vol.18, pp.632-644, 2016.

C. J. Whatcott, C. H. Diep, P. Jiang, A. Watanabe, J. Lobello et al., Desmoplasia in Primary Tumors and Metastatic Lesions of Pancreatic Cancer, Clin Cancer Res, vol.21, pp.3561-3568, 2015.

C. J. Whatcott, H. Hanl, V. Hoff, and D. D. , Orchestrating the Tumor Microenvironment to Improve Survival for Patients With Pancreatic Cancer Normalization, Not Destruction, Cancer J, vol.21, pp.299-306, 2015.

K. R. Wiehagen, N. M. Girgis, D. H. Yamada, A. A. Smith, S. R. Chan et al., Combination of CD40 Agonism and CSF-1R Blockade Reconditions Tumor-Associated Macrophages and Drives Potent Antitumor Immunity, Cancer Immunol Res, vol.5, pp.1109-1121, 2017.

E. Wieland, J. Rodriguez-vita, S. S. Liebler, C. Mogler, I. Moll et al., Endothelial Notch1 Activity Facilitates Metastasis, vol.31, pp.355-367, 2017.

T. N. Wight, Versican: a versatile extracellular matrix proteoglycan in cell biology, Curr. Opin. Cell Biol, vol.14, pp.617-623, 2002.

K. Wing, Y. Onishi, P. Prieto-martin, T. Yamaguchi, M. Miyara et al., CTLA-4 Control over Foxp3+ Regulatory T Cell Function, Science, vol.322, pp.271-275, 2008.

A. K. Witkiewicz, E. A. Mcmillan, U. Balaji, G. Baek, W. Lin et al., Whole-exome sequencing of pancreatic cancer defines genetic diversity and therapeutic targets, Nat Commun, vol.6, p.6744, 2015.

B. M. Wolpin, C. Rizzato, P. Kraft, C. Kooperberg, G. M. Petersen et al., Genome-wide association study identifies multiple susceptibility loci for pancreatic cancer, Nat. Genet, vol.46, pp.994-1000, 2014.

S. M. Wörmann, K. N. Diakopoulos, M. Lesina, A. , and H. , The immune network in pancreatic cancer development and progression, Oncogene, vol.33, pp.2956-2967, 2014.

Z. Wu, T. Brabletz, E. Fearon, A. L. Willis, C. Y. Hu et al., , 2012.

, Canonical Wnt suppressor, Axin2, promotes colon carcinoma oncogenic activity, Proc Natl Acad Sci U S A, vol.109, pp.11312-11317

J. B. Wyckoff, Y. Wang, E. Y. Lin, J. Li, S. Goswami et al., Direct Visualization of Macrophage-Assisted Tumor Cell Intravasation in Mammary Tumors, Cancer Res, vol.67, pp.2649-2656, 2007.

T. Xie, F. Huang, K. D. Aldape, S. Kang, M. Liu et al., Activation of stat3 in human melanoma promotes brain metastasis, Cancer Res, vol.66, pp.3188-3196, 2006.

Z. Xie, X. Chen, J. Li, Y. Guo, H. Li et al., , 2016.

, Salivary HOTAIR and PVT1 as novel biomarkers for early pancreatic cancer, vol.7, pp.25408-25419

Z. Xu, A. Vonlaufen, P. A. Phillips, E. Fiala-beer, X. Zhang et al., Role of Pancreatic Stellate Cells in Pancreatic Cancer Metastasis, Am J Pathol, vol.177, pp.2585-2596, 2010.

S. Yachida, S. Jones, I. Bozic, T. Antal, R. Leary et al., Distant Metastasis Occurs Late during the Genetic Evolution of Pancreatic Cancer, Nature, vol.467, pp.1114-1117, 2010.

D. K. Yadav, X. Bai, R. K. Yadav, A. Singh, G. Li et al., , 2018.

, Liquid biopsy in pancreatic cancer: the beginning of a new era, Oncotarget, vol.9, pp.26900-26933

P. Yan, H. Zhu, L. Yin, L. Wang, P. Xie et al., Integrin ?v?6 Promotes Lung Cancer Proliferation and Metastasis through Upregulation of IL-8-Mediated MAPK/ERK Signaling, Transl Oncol, vol.11, pp.619-627, 2018.

X. Yang, Y. Lin, Y. Shi, B. Li, W. Liu et al., FAP Promotes Immunosuppression by Cancer-Associated Fibroblasts in the Tumor Microenvironment via STAT3-CCL2 Signaling, Cancer Research, vol.76, pp.4124-4135, 2016.

D. A. Yardley, nab-Paclitaxel mechanisms of action and delivery, J Control Release, vol.170, pp.365-372, 2013.

S. Yeo, K. Lee, D. Shin, S. An, K. Cho et al., A positive feedback loop bi-stably activates fibroblasts, Nat Commun, vol.9, p.3016, 2018.

J. M. Yi, A. A. Guzzetta, V. J. Bailey, S. R. Downing, L. Van-neste et al., Novel methylation biomarker panel for the early detection of pancreatic cancer, Clin. Cancer Res, vol.19, pp.6544-6555, 2013.

J. I. Yook, X. Li, I. Ota, C. Hu, H. S. Kim et al., A Wnt-Axin2-GSK3beta cascade regulates Snail1 activity in breast cancer cells, Nat. Cell Biol, vol.8, pp.1398-1406, 2006.

J. Youn and D. I. Gabrilovich, The biology of myeloid-derived suppressor cells: The blessing and the curse of morphological and functional heterogeneity, Eur J Immunol, vol.40, pp.2969-2975, 2010.

D. Yu, T. Zhang, K. Wu, Y. Li, J. Wang et al., MicroRNA-448 suppresses metastasis of pancreatic ductal adenocarcinoma through targeting JAK1/STAT3 pathway, Oncol. Rep, vol.38, pp.1075-1082, 2017.

M. Yu, D. T. Ting, S. L. Stott, B. S. Wittner, F. Ozsolak et al., RNA sequencing of pancreatic circulating tumour cells implicates WNT signalling in metastasis, Nature, vol.487, pp.510-513, 2012.

X. Yu, S. Ji, J. Xu, W. Yao, B. Qu et al., , 2012.

, CD8+ T Cells Are Compromised In Human Pancreatic Cancer, Translational Medicine, vol.2, pp.1-4

Y. X. Yu, H. J. Wu, B. X. Tan, C. Qiu, and H. Z. Liu, CSF-1R regulates non-small cell lung cancer cells dissemination through Wnt3a signaling, Am J Cancer Res, vol.7, pp.2144-2156, 2017.

A. Zhang, Y. Qian, Z. Ye, H. Chen, H. Xie et al., , 2017.

, Cancer-associated fibroblasts promote M2 polarization of macrophages in pancreatic ductal adenocarcinoma, Cancer Med, vol.6, pp.463-470

Y. Zhao, J. Sun, H. Zhang, S. Guo, J. Gu et al., High-frequency aberrantly methylated targets in pancreatic adenocarcinoma identified via global DNA methylation analysis using methylCap-seq, Clin Epigenetics, vol.6, p.18, 2014.

Y. Zheng and Z. Lu, Paradoxical roles of FAK in tumor cell migration and metastasis, Cell Cycle, vol.8, pp.3474-3479, 2009.

X. Zheng, J. L. Carstens, J. Kim, M. Scheible, J. Kaye et al., Epithelial-to-mesenchymal transition is dispensable for metastasis but induces chemoresistance in pancreatic cancer, Nature, vol.527, pp.525-530, 2015.

Y. Zhi, M. Song, P. Wang, T. Zhang, and Z. Yin, Suppression of matrix metalloproteinase-2 via RNA interference inhibits pancreatic carcinoma cell invasiveness and adhesion, World J. Gastroenterol, vol.15, pp.1072-1078, 2009.

Y. Zhong, A. Macgregor-das, T. Saunders, M. C. Whittle, A. Makohon-moore et al., Mutant p53 Together with TGF? Signaling Influence Organ-Specific Hematogenous Colonization Patterns of Pancreatic Cancer, Clin. Cancer Res, vol.23, pp.1607-1620, 2017.

B. Zhou, J. Xu, Y. Cheng, J. Gao, S. Hu et al., Early detection of pancreatic cancer: Where are we now and where are we going?, Int. J. Cancer, vol.141, pp.231-241, 2017.

Y. Zhu, B. L. Knolhoff, M. A. Meyer, T. M. Nywening, B. L. West et al., CSF1/CSF1R blockade reprograms tumor-infiltrating macrophages and improves response to T-cell checkpoint immunotherapy in pancreatic cancer models, Cancer Res, vol.74, pp.5057-5069, 2014.

Y. Zhu, J. M. Herndon, D. K. Sojka, K. Kim, B. L. Knolhoff et al., Tissue-Resident Macrophages in Pancreatic Ductal Adenocarcinoma Originate from Embryonic Hematopoiesis and Promote Tumor Progression, Immunity, vol.47, pp.323-338, 2017.

Y. Zou, J. Li, Z. Chen, X. Li, S. Zheng et al., miR-29c suppresses pancreatic cancer liver metastasis in an orthotopic implantation model in nude mice and affects survival in pancreatic cancer patients, Carcinogenesis, vol.36, pp.676-684, 2015.

A. Zwenger, M. Rabassa, S. Demichelis, G. Grossman, A. Segal-eiras et al., High expression of sLex associated with poor survival in Argentinian colorectal cancer patients, Int. J. Biol. Markers, vol.29, pp.30-39, 2014.